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ABSTRACT
Cytochromes P450 monooxygenases play important roles on oxidative 
decoration of secondary metabolites in Streptomycetes.
Cytochrome P450 158A2 (CYP158A2) and CYP158A1 of Streptomyces 
coelicolor A3 (2) are two of the 18 CYPs that comprise the CYP complement or 
“CYPome” of S. coelicolor A3(2). CYP158A2 catalyzes an unusual oxidative C-C 
coupling reaction to polymerize flaviolin (a red pigment) into three isomers of 
biflaviolin and one triflaviolin which are pigments responsible for UV radiation 
protection in Streptomyces. Although located in a different part of the chromosome, 
CYP158A1, sharing 61% aminoacid identity with CYP158A2, has also been shown 
to produce almost identical flaviolin-derived products.
The gene sco!207 encoding for CYP158A2 was previously deleted and this 
mutant showed no changes on phenotype with respect to the wild type. Given that the 
production of the same flaviolin-derived compounds can be achieved as well by 
CYP158A1, this CYP is thought to be the substitute for CYP158A2 in the 
biosynthesis of those pigments, enforcing the mechanism for UV protection in these 
organisms.
In order to investigate functional redundancy between CYP158A1 and 
CYP158A2, PCR-based targeted mutagenesis was carried out to delete the gene 
sco6998 encoding for CYP158A1 in a wild type strain (to create a single mutant) and 
in a strain with the gene for CYP158A2 already deleted (to create a double mutant 
for both genes). Phenotype observation of the mutants and metabolomic studies by 
mass spectrometry analyses were carried out in order to identify and quantify the 
amount of flaviolin in every mutant compared to the parental strain. Furthermore UV 
sensitivity assays were performed to measure the effect of the lack of those pigments.
The results obtained will shed light in the understanding of the function of 
such valuable and diverse proteins as are the CYPs, and highlight the importance of 
this pathway in the production of novel secondary metabolites with important 
biological activities.
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1 INTRODUCTION
1.1 CYTOCHROMES P450
1.1.1 Generalities
Cytochromes P450 (CYPs) are a superfamily of haemoproteins which are 
widely distributed in nature. They owe their name to the fact that they produce a 
peak at 450 nm when they are reduced with sodium dithionite in presence of carbon 
monoxide (Omura and Sato, 1962). Many studies on these enzymes have been 
carried out in humans due to their importance in the metabolism of xenobiotic drugs. 
They were first identified in 1958 by Klingenberg et al in mammalian liver 
microsomal samples and since then multiple studies have targeted these enzymes in 
all kind of organisms (Kelly et a l , 2003).
Diversity is one of the most remarkable features of this superfamily. 
Members of this superfamily can be found in prokaryotes and eukaryotes. Humans 
have around 57 genes for these proteins while Drosophila melanogaster has 90, the 
plant Arabidopsis thaliana has 257 and the bacterium Escherichia coli has none 
(Kelly et al., 2003). Not only are there differences in the number of genes between 
the organisms but also in structure, function and metabolism. There are only a few 
conserved features between organisms that determine the identity of this superfamily.
The average protein fold shows a triangular prism structure.
A few conserved amino-acid domains can be found. The only 
amino-acid absolutely conserved is the cysteine ligand to the prosthetic haem. 
Other invariant residues in most CYPs are arginine and glutamic acid within 
the EXXR domain in K-helix (Rupasinghe et al., 2006). A threonine is 
frequently found in the I-helix associated with oxygen activation and electron 
transfer (Kelly et a l, 2003).
These enzymes are classified into families and subfamilies on the basis of 
amino-acid identity. Thus, one particular enzyme belongs to a family when shares at 
least 40 % of amino-acid sequence identity with members of that family or belongs
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to a subfamily when the identity percentage is 55% or higher. A nomenclature has 
been established for these enzymes by Dr. David Nelson (Cytochrome P450 
homepage, http://dmelson.utmem.edu/CvtochromeP450.htmiy The families are 
assigned with a number, followed by a letter which corresponds to the subfamily, 
followed as well by another number which indicates the order of discovery of that 
particular enzyme. For each group of organisms a range of numbers has been set: 
from 1 to 49 for animals, 51 to 69 for lower eukaryotes, 71 to 99 for plants and from 
101 for bacteria. However, new CYPs are being discovered as new data is being 
obtained from the complete sequence of genomes, therefore lower eukaryotes 
families are being expanding from CYP501 and plant families from 701 (Kelly et a l , 
2003).
Eukaryotic CYPs are found in two cellular locations, associated with the 
endoplasmic reticulum and mitochondrial membranes. They were once considered as 
liver specific proteins due to their high concentration in liver cells, however they 
have been found in many other locations since then (Bruno and Njar, 2007). In 
prokaryotes P450s are soluble proteins according to what is known so far (Werck- 
Reichhart et a l , 2000b).
CYPs can be classified on the basis of several criteria. According to the kind 
of electron transfer system and redox partners they use, there are at least 3 classes of 
CYPs (Ortiz de Montellano, 1995):
CYPs of Class I use an iron-sulfur protein (fenredoxin) and a 
ferredoxin reductase. Bacterial and mitochondrial CYPs are included in this 
class.
The Class II enzymes are the microsomal (eukaryotic) CYPs 
which receive electrons from a NADPH Cytochrome P450 Reductase (CPR) 
which contains FAD and FMN cofactors.
Other forms of P450s have been found which are self- 
sufficient and do not require electron donors. Among them fusion molecules 
of P450 and CPR such as CYP102A1 (also known as BM-3) (Girvan et a l, 
2007), CYP55 (Takaya et al, 2002), and CYP74 subfamily proteins which do
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not require any other electron donor protein (Stumpe and Feussner, 2006), are 
noteworthy.
The wide distribution in the organisms of this superfamily of proteins leads to 
the hypothesis that they had an early origin (Deng et a l , 2007). It has been estimated 
that the first P450 emerged around 3.5 billion years ago, in an ancestral prokaryotic 
species, shortly after the origin of terrestrial life (Lewis et a l, 1998). In these 
reducing atmospheric conditions, P450s might have been originated to detoxify 
reactive oxygen species (Wickramasinghe and Ville, 1975). When the concentration 
of oxygen in the atmosphere dramatically increased, around 2 billion years ago, the 
functions of these proteins were probably redirected towards the utilisation of 
dioxygen for the metabolism of endogenous compounds to yield products as sterols, 
and xenobiotics (Lewis et a l, 1998). The evolution of these proteins from this 
moment on is mainly due to gene duplications that occurred for the first time around 
900 million years ago. Each new cell lineage produced by them adapted to perform 
one particular function. Since then, more gene duplications and other changes have 
occurred and probably, the exposure of organisms to several chemical substances has 
accelerated the diversification process (Nelson and Strobel, 1987).
1.1.2 Structure of CYPs
The protein fold of the cytochromes P450 is quite conserved. The first crystal 
structure was obtained in 1985 for CYP101A1 from Pseudomonas putida by Poulos 
et a l The characteristic triangular prism structure of these enzymes has been 
observed in other CYPs in posterior crystal structure studies. P450s have a unique 
structure, as no non-P450 structure has been found to have the same fold (Kelly et 
al, 2003). This fold is necessary for the protein to be able to carry out oxygen 
activation, binding of redox partners, and stereochemical requirements of substrate 
recognition (Ortiz de Montellano, 1995).
A scheme of this triangular prism structure is shown in the figure 1 below:
3
Figure 1. CYP158A1 Structure. The haem group is shown as the balls and sticks structure in the
center of the protein (Zhao et al., 2007).
Although the general fold is maintained, several structural elements present 
differences between organisms. The most conserved elements are the ones situated 
closest to the haem group, such as I and L helix while the most variable regions are 
those that control substrate specificity (especially B helix) (Werck-Reichhart and 
Feyereisen, 2000b). This structure undergoes as well conformational changes during 
the catalytic cycle to accommodate the substrate in the binding site (Zhao et al., 
2005;Zhao et a l, 2007).
The following are structural elements with mechanistic or structural 
importance which can be found generally in all the CYPs (Lewis et al., 1998):
A 10 amino-acid motif at the start of the L-helix, including the 
cysteine ligand to the haem iron. This motif usually takes the form 
FxxGxxxCxG where F  is Phenylalanine, G is Glycine, C is Cysteine and x is 
any amino-acid.
A tetrapeptide in the K helix which takes the form ExxR where 
E  is glutamate, R is arginine and a; any amino-acid.
A frequent threonine residue in the I-helix associated with 
oxygen activation.
1.1.3 Function and mechanism of action
Cytochrome P450-dependent monooxygenases are haem-thiolate proteins 
that contain an iron-protoporphynn IX center coordinated to a cysteine thiolate. The 
main function of these enzymes is the monooxygenation of a wide range of
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compounds (Ortiz de Montellano, 1995). This reaction requires the activation of 
molecular oxygen which is carried out by the transfer of electrons from the reduction 
of NAD(P)H by a short electron-transport chain (Werck-Reichhart et a l , 2000b).
The activation of molecular oxygen occurs at the iron center, where the two 
atoms of oxygen in the molecule are separated One of the atoms is incorporated into 
a wide variety of biological substrates and the other one is transformed into water 
(Ortiz de Montellano, 1995;Zhao et al, 2005). The general catalytic cycle of these 
enzymes is shown in the next scheme:
ROH
Figure 2. The catalytic cycle of CYPs. Steps: 1, substrate binding. 2, electron transfer. 3, dioxygen 
binding. 4, second electron transfer. 5, protonation and splitting of the oxygen-oxygen bond, with 
release of water. 6, reaction of Fe03+with substrate to form product, and product dissociation.
The substrate binds to the enzyme through the active site which is the haem 
group in the center of the protein. The enzyme needs now to bind molecular oxygen 
to perform its activation. In order to reduce ferric cytochrome P450 to a ferrous form, 
an electron from the reduction of NADPH is transferred to the enzyme by an 
associated reductase. In this form, the cytochrome P450 is able to bind oxygen. The 
acceptance of another electron and posterior protonation leads to the cleavage of the 
0 -0  bond and the release of water. The remaining intermediate transfers the oxygen 
to the substrate to form the oxygenated product complex. The cycle is completed 
when this product is dissociated (Zhao et a l, 2005).
These enzymes catalyse a wide array of chemical reactions, such as 
epoxidations, c-hydroxylations, oxygenation, aromatic dehalogenation, reductions,
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oxidative rearrangements and oxidative coupling reactions (Ortiz de Montellano, 
1995;Zhao et al, 2005;Lamb et al, 2007).
Further to their well-known role in detoxification of xenobiotic drugs and 
toxic chemicals, CYPs are also involved in the development of strategies for 
deterrence and attraction, as well as in bioremediation, being responsible for 
biotransformation of diverse compounds. They have the ability to produce more 
diverse toxic metabolites, and at the same time they possess mechanisms to detoxify 
them. Not only are these proteins important in secondary metabolism pathways, as 
in oxidative tailoring of antibiotics and other bioactive compounds, but they are also 
interestingly involved in the biosynthesis of primary metabolites such as sterols, 
steroids, fatty acids and prostaglandins. They are also potential drug targets 
important for antifungal and anti-protozoan agents (Kelly et a l, 2003;Kelly et al, 
2006).
Their role in the oxidative modification of diverse compounds to provide 
them biological activities is gaining great importance nowadays due to the need of 
discovery of novel compounds with application in medicine and agriculture. CYPs 
participate in modification of polyketides, non-ribosomal peptides and terpenes to 
produce compounds such as antibiotics, anti-oxidants, anticancer drugs, or antifungal 
agents amongst others (Ringer et al, 2005;Ro et a l, 2006;Butz et a l, 2008).
1.2 STREPTOMYCETES
1.2.1 Introduction
Streptomycetes are gram-positive soil filamentous bacteria which are 
ubiquitous in nature. They produce the vast majority of the natural antibiotics used in 
human and veterinary medicine as well as in agriculture nowadays and other classes 
of biologically active secondary metabolites such as antiparasitic agents, 
immunnosuppresors, or herbicides. These organisms are responsible of several 
transformations of xenobiotics, and have an important role in soil biodegradation by
6
decomposing recalcitrant polymers thanks to the extracellular enzymes they produce 
(Kieser et a l , 2000).
They have a complex life cycle, similar to fungi’s, which involves formation 
of two different kind of typical mycelia (aerial and substrate) and sporulation. The 
cycle starts when a spore finds the necessary soluble nutrients in the medium and 
germinates. Once they have adapted to the existent conditions, they grow 
exponentially as branching hyphae filaments within the medium. When 
environmental conditions are unfavourable, such as shortage of nutrients or other 
environmental stress, the so called stationary phase starts. This phase is characterised 
by the reduction of cell proliferation and the production of aerial mycelium. 
(Chakraburtty and Bibb, 1997;Hesketh et a l, 2007).
The production of aerial mycelium is achieved at the expense of the substrate 
mycelium. Part of the latter is broken and nutrients are released which are used for 
the formation of the aerial hyphae. As well, the tips of these hyphae undergo multiple 
cell divisions to generate a string of unigenomic compartments which will become 
the spores (Chater, 2001;Hesketh et a l, 2007). It is also in this phase of growth, 
when they produce different compounds that will permit them to survive in such an 
inhospitable medium as soil. These products are of very different natures such as 
extracellular enzymes which allow them to use non-soluble nutrients, or secondary 
metabolite like antibiotics, to get rid of competitors, or pigments to protect 
themselves against UV irradiation (Chater, 2006). Figure 3 shows a scheme of this 
cycle.
Spore
Germination
S ubstra te
Mycelium
Aerial mycelium 
formation 
Secondary metabolites 
production
Figure 3. Streptomyces Life Cycle.
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1.2.2 Streptomyces coelicolor
Streptomyces coelicolor is the most genetically studied member of the genus. 
It is a model organism for Streptomyces which synthesizes a wide array of secondary 
metabolites. Recently, some of these secondary metabolites of S. coelicolor have 
received attention for utilization in medicine such as prodiginines (Williamson et al.,
2006).
S. coelicolor produce several chemically diverse antibiotics. The most notable 
ones are actinoihodin and undecylprodigiosin as they are pigmented antibiotics. 
Actinorhodin, a pH indicator (turning red below a pH of 8.5 and blue above) was the 
first studied genetically in S. coelicolor A3(2). Undecylprodigiosin is a mixture of at 
least four prodigiosins with undecylprodigiosin and butylcycloheptylprodiginine 
predominating. They also produce methylenomycin, a SCP-1 plasmid encoded 
antibiotic, and CD A, calcium-dependant antibiotic (Kieser etal., 2000).
Since the genome of the strain A3(2) was completely sequenced in 2001 by 
the Sanger Centre at Hinxton, Cambridge (UK), genes for novel pathways of 
secondary metabolism were first identified, such as genes encoding cytochromes 
P450 among others. A figure showing the structure of antibiotics and other secondary 
metabolites known or predicted to be made by S. coelicolor can be found in Bentley 
etal. (2002).
13 CYTOCHROMES P450 IN STREPTOMYCETES
13.1 Introduction
In Streptomycetes, CYPs seem to be involved, directly or indirectly, in 
secondary metabolism functions and xenobiotic transformations. Genes for these 
CYPs are often associated in clusters with genes encoding proteins responsible for 
the biosynthesis of secondary metabolites. This organization of genes is widely 
conserved in streptomycetes suggesting a general role of these proteins in secondary 
metabolism in these organisms. CYP monooxygenases accomplish reactions of 
polyketides, nonribosomal peptides and terpenes post-modification, contributing to
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the biological properties of these compounds. Furthermore, some of these proteins 
have the ability to oxidise a wide array of metabolites, therefore theirs could be the 
responsibility for the xenobiotic transformations catalysed by these organisms (Kelly 
etal., 2003).
Very little is known about the function of most of the CYPs in 
Streptomycetes. The sequence homology with other CYPs can give us an idea of the 
function of these proteins. However, their real function can only be confirmed by 
functional genomic procedures, such as targeted mutagenesis of the genes encoding 
for these proteins.
1.3.2 S. coelicolor A3(2) CYPome
S. coelicolor A3(2) possess 18 CYPs, as was revealed from the information 
obtained from the sequenced genome (Bentley et a l, 2002). This cytochrome P450 
(CYP) complement or “CYPome” was described in 2002 by Lamb et. al (Lamb et 
al, 2002b). In order to achieve this, the genome was subjected to bioinformatic 
analysis and then the putative CYPs were heterologously expressed in E. coli and 
assayed by sodium dithionite-reduced carbon monoxide difference 
spectrophotometry. The latter assay reveals the characteristic Soret maximum around 
450 nm indicative of these proteins. Their amino-acid sequence was compared with 
other CYPs of related organisms. Most of them were homologous to CYPs involved 
in secondary metabolism, or were found next to other proteins which could be 
involved in secondary metabolism.
CYP51 is the only CYP found in bacteria, plants, fungi, protists and animals. 
It is a sterol 14-demethylase required for sterol biosynthesis and was first discovered 
in yeast by Kalb et al., in 1987 (Kelly et a l, 2003). In S. coelicolor a CYP51-like 
protein has been found with low-level homology to other CYP51. This protein, 
despite having sterol 14-demethyl ase activity, does not produce sterols and must play 
another role in this organism, non-essential for its growth and survival (Lamb et al., 
2002a). It has been recently reported that this protein belongs to the CYP170 family 
of proteins. This so called CYP170A1 catalyses sequential allylic oxidations of the
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sesquiterpene epi-isozizaene to yield the antibiotic albaflavenone in vitro (Zhao et 
a l , 2008).
CYP105D5 from S. coelicolor shares more than 90% of amino-acid identity 
with CYP105D4 from S. lividans and 69.5% of amino-acid identity with CYP105D1 
from S. griseus. It has been reported than the CYP105 family of proteins play an 
important role in biotransformation and bioremediation (Lamb et a l, 2002b). In fact, 
CYP105D4 from S. lividans, is encoded within the AUD4 gene cluster, which is an 
amplifiable element or amplifiable unit of DNA. Amplifications of DNA can be 
interpreted as a response to the demand of higher resistance to toxic metals or 
antibiotics (Schmid et al, 1999). CYP105D1 from S. griseus has been reported to be 
able to catalyse transformation by oxidation of several xenobiotic compounds, such 
as benzopyrene, erythromycin, warfarin and testosterone (Taylor et al, 1999).
CYP107 family is, as well as the CYP 105 family, associated with xenobiotic 
and secondary metabolism (Lamb et al, 2003). Three members of this family were 
found in S. coelicolor, CYP107U1, CYP107P1 and CYP107T1 although they are not 
linked to any secondary metabolite gene clusters.
CYP156A1 and CYP154A1 are homologous to CYPs with known function 
involved in secondary metabolism, such as the antibiotic tylosin biosynthesis in S. 
fradiae. They are located adjacent on the same strand which suggests polycistronic 
translation (Lamb et al, 2002b). The structures of CYP154A1 and CYP154C1 have 
been determined and found to catalyse different substrates despite of their similarity 
in amino-acid sequence (Podust et a l, 2004). CYP157A1 and CYP154C1 are also 
located adjacent in the chromosome and are part of a so called conservon together 
with a sensor kinase and an ATP binding protein among other genes, which suggests 
as well involvement in secondary metabolism. In fact, CYP154C1 has been found to 
catalyse hydroxylation of precursors of macrolide antibiotics in S. venezuelae 
(Podust et a l, 2004). CYP105N1 is also located in an operon including a non- 
ribosomal peptide synthase, a thioesterase, and an ABC transporter.
CYP158A2 shares 81.4% identity with a CYP from S. avermitilis 
(CYP158A3), and both of them are in the same locus, which is adjacent to a
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polyketide synthase (PICS) (Lamb et al, 2002b). These CYP catalyses the coupling 
of two flaviolin molecules to produce dimers and trimers which are thought to be 
pigments for the protection against ultraviolet irradiation (Zhao et al, 2005). 
CYP158A1 is as well similar to a CYP of S. avermitilis. It has been reported that 
these CYP also uses flaviolin as substrate to yield almost identical flaviolin 
derivatives, although by a different substrate binding mechanism (Zhao et a l, 2007).
Different and varied roles have been associated to these proteins. A project to 
determine the function of the 18 CYPs forming the CYPome of S. coelicolor A3 (2) is 
ongoing. It is believed that many other novel interesting functions will be found 
(Zhao and Waterman, 2007).
1.3.3 Gene organization
CYP monooxygenases accomplish reactions of polyketides post- 
modification, contributing to the biological properties such as antibiotic potency and 
efficacy in Streptomycetes (Kelly et a l, 2003). Genes for these CYPs are frequently 
associated in clusters with genes for polyketide synthases (PKS) in these organisms. 
This organization of genes is widely conserved among Streptomycetes. A 
comparison of this gene organization in several actinomycetes species is shown in 
figure 4.
The gene rppA encoding a type IE Polyketide synthase (1,3,6,8- 
tetrahydroxynaphtalene (THN) synthase) was first described in S. griseus. In this 
bacterium P450mel is the enzyme responsible for post-modification of the polyketide 
THN. The gene p450mel is associated in cluster with rppA. A gene with high amino- 
acid sequence similarity to P450mel has also been found in S. coelicolor (gene for 
CYP158A2), Saccharopolyspora erythraea or S. avermitilis but not in S. antibioticus 
(Figure 4). In S. antibioticus another gene, momA encoding for a quinone-forming 
monooxygenase has been found associated in cluster with rppA. Homologues to this 
gene momA have also been found in S. coelicolor, S. avermitilis and S. erythraea 
forming a three gene operon with rppA and homologues of p450mel.
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Figure 4. Organization of rppA and P450 genes in several species of actinomycetes (Funa et al.,
2005b).
To corroborate that the type HI PKS encoded by gene rppA was involved in 
the biosynthetic pathway of pigments which provide protection against UV radiation 
in actinomycetes, this gene was inactivated in S. griseus and Saccharopotyspora 
erythraea. An albino phenotype was observed in these mutants (Cortes et al., 
2002;Funa et al., 2005a). However, the same disruption experiments carried out with 
their homologous gene scol206 encoding for THN synthase (THNS) or scol207 
encoding for CYP158A2, led to no changes in phenotype of the mutants (Funa et al, 
2005a;Zhao etal., 2007).
Recently, a THNS has been identified as well in S. peucetius sharing 33% 
identity with the THNS encoded in the gene scol206 of S. coelicolor and 32% 
identity with RppA in S. griseus. This protein synthesises THN which is 
spontaneously oxidised to flaviolin (Ghimire et al., 2008).
13.4 CYP158A2 and CYP158A1
CYP158A2 and CYP158A1 share 61.2% of aminoacid identity (Lamb et al., 
2002b). These two monooxygenases catalyse the oxidative coupling of two flaviolin 
molecules to yield pigments for the protection against UV irradiation, although by 
different mechanisms (Zhao eta l, 2007).
CYP158A2 was investigated functionally and structurally in 2005 (Zhao et 
al, 2005). It is encoded in a three-gene operon (scol206-scol208) together with
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gene rppA encoding a type DI Polyketide synthase and ORF3 (Izumikawa et al, 
2003) which presents similarity of amino-acid sequence with the gene momA, first 
described in S. antibioticus (Funa et al, 2005b).
P450mel, also called CYP158B1, catalyses aryl coupling of THN to yield 
l,4,6,7,9,12-hexahydroxyperylene-3,10-quinone (HPQ). HPQ polymerises non- 
enzymatically to yield brownish pigment called HPQ-melanin. These melanin-like 
pigments are usually biosynthesised via dihydroxyphenylalanine (DOPA) in most 
Streptomyces species, as well as in other microorganisms, plants or animals (Funa et 
al, 2005a). THN can also be transformed into 1,8-dihydroxynaphthalene (DHN) 
which polymerises to produce DHN-melanin. In fungi, a type I PKS is involved in 
this process (Plonka and Grabacka, 2006).
CYP158A2 sharing only 46% of amino-acid sequence with P450mel 
catalyses the same aryl-coupling reaction. CYP158A2 uses the red-brown pigment 
flaviolin (2,5,7-trihydroxy-l,4-naphtoquinone, see figure 5) as substrate and 
produces 4 different dimeric and trimeric products by oxidative coupling.
The structure of two of these dimeric products has been characterized by 
Zhao et a l (2005) by mass spectrometry and NMR (Nuclear Magnetic Resonance) 
methods. They have been established as 3,8’-biflaviolin, a non-symmetrical flaviolin 
C-C dimer, and the symmetric 3,3’-biflaviolin. The other two products were another 
dimer and a trimer. These flaviolin dimers and trimers are red-brown pigments that 
seem to protect the bacterium from UV radiation.
O H
Figure 5. Flaviolin, 2,5,7-trihydroxy-1,4-napthoquinone.
To produce these dimeric products this enzyme binds two molecules of 
flaviolin in the active site. The protein has to undergo conformational changes to 
accommodate the two molecules at the same time. A comparison of the crystal
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structure of the substrate-free protein and the substrate-complex shows how the 
former presents a more open conformation to allow the substrate the access to the 
active site (see figure 6). In this structure the F/G helices are rotated out of the active 
site so that the cleft reflects a gap between F helix and b-sheet 4. On the other hand, 
when the substrate is bound to the protein, the access channel closes. The protein 
undergoes significant conformational change, which represent over the 35% of the 
amino-acid sequence of CYP158A2 (Zhao et a l, 2005).
Figure 6. Diagram of the crystal structure of CYP158A2 in a substrate-free state (a) showing an open 
configuration, and when the substrate is bound (b) showing a closed configuration. The group haem is 
shown in red in the center of the protein. The substrate flaviolin is shown in blue. (Zhao et al., 2005).
Flaviolin is the product of the oxidation of the polyketide THN, synthesised 
by the action of RppA from five molecules of Malonyl-CoA (figure 7). In S. 
coelicolor this reaction was proposed to be spontaneous. Later in other 
actinomycetes, such as S. antibioticus and Saccharopolyspora erythraea this reaction 
was found to be catalysed by a protein, product of gene momA which has been 
characterised as a quinone-forming monooxygenase (Funa et al., 2005b). This gene 
momA has been found next to rppA in several actinomycetes species and it shares 
58% of amino-acid sequence with ORF3 of S. coelicolor.
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Figure 7. Biosynthetic Pathway of flaviolin and melanin-like pigments in actinomycetes. MomA 
is present in Streptomyces antibioticus, S. coelicolor, S. avermitilis, and Saccharopotyspora erythraea.
P450mel, also called CYP158B1, has been found in S. griseus, as well as in S', avermitilis or S. 
erythraea. In S', coelicolor CYP158A2 is the cytochrome responsible of modification of flaviolin.
DHN-melanin pathway occurs in fungi with a type I instead of type III PKS involved.
A homologue of momA has been found in S. coelicolor A3 (2). This gene, 
whiE-ORFII, which shows similarity in amino-acid sequence with momA, catalyses 
as well the oxygenation of THN to produce flaviolin. It is located within whiE gene 
cluster, for the biosynthesis of a grey spore pigment (Funa et a l, 2005a).
In fungi, flaviolin has been found to be a shunt metabolite, not an 
intermediate but a product of the accumulation of other intermediates, of the 
biosynthetic pathway of DHN melanin (Bell et al., 1976;Wheeler and Stipanovic, 
1985;Dahiya and Rimmer, 1988;Romero-Martinez et al., 2000).
Flaviolin can also be the precursor of other compounds as it has been reported 
for other actinomycetes (figure 7). MomA has also been reported to be involved in 
the modification of flaviolin to yield mompain in S. antibioticus (Funa et al., 2005a). 
Derivatives of flaviolin have been found to be constituents of the diffusible red
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pigment produced by Saccharopolyspora erythraea, in which biosynthesis a type HI 
PKS is involved (Cortes et al., 2002).
In S. cinnamonensis Fnq26 was described as a prenyltransferase which can 
catalyze C- and O- prenylations of different phenolic substrates. fnq26 forms part of 
the biosynthetic gene cluster for the prenylated polyketide furanonaphtoquinone 1 
(FNQ 1) in this bacterium. When using flaviolin as substrate this enzyme catalyzes a 
reverse C-prenylation, which is the formation of a C-C bond between C3 of geranyl 
diphosphate (GPP) and C3 of flaviolin (the normal (non-reverse) prenylation is the 
formation of a bond between Cl of GPP and C3 of flaviolin). It has been reported, 
however, that flaviolin is not the substrate of Fnq26 to produce FNQ 1, but probably 
an intermediate in the biosynthesis of flaviolin from Malonyl-CoA (Haagen et a l,
2007). In Streptomyces sp. strain CL 190 a prenyltransferase is involved in the 
biosynthesis of the anti-oxidant naphterpin. This enzyme could use flaviolin and 
other THN derivatives as substrate in vitro. However, flaviolin was not the substrate 
of this enzyme in the biosynthesis of this anti-oxidant, and the actual substrate has 
not yet been determined. In S. coelicolor the protein HypSc has also been seen to 
catalyse prenylation of THN derivatives (Kuzuyama et a l, 2005).
CYP158A1 is encoded for the gene sco6998 in a different part of the 
chromosome of S. coelicolor and is not organised in an operon with other genes. 
This CYP uses flaviolin as well as substrate to yield almost identical flaviolin 
derivatives. But the mechanism in which this protein couples flaviolins is not the 
same (Zhao et al., 2007). The active site of CYP158A1 is different from that of 
CYP158A2. When a flaviolin is bound to the active site of CYP158A1 there is not 
enough space for a second one to bind in the proximal zone of the active site, as 
occurred with CYP158A2, therefore the two flaviolins are more separated. However, 
this coupling although different from that for CYP158A2 leads to the same products, 
3,8’-biflaviolin and 3,3'-biflaviolin, although in a different ratio. The other two 
products yield by CYP158A2, another flaviolin dimer and a flaviolin trimer were not 
observed with CYP158A1 (Zhao et al, 2007).
Flaviolin derivatives are thought to be pigments for the protection of S. 
coelicolor against UV irradiation. Disruption of the gene encoding for P450mel
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(CYP158B1) a homologous of CYP158A2, in S. griseus increased the sensitivity of 
the mutant against UV irradiation (Funa et a l, 2005a). Mutagenesis experiments to 
disrupt the gene scol207 encoding for CYP158A2 have been carried out in order to 
elucidate the role of this protein in this bacterium (figure 8) (Skaug, 2006). However, 
pigmentation or metabolic profiling with HPLC/mass spectrometry using different 
extraction procedures and culture conditions did not reveal differences from the 
parental strain (Funa et a l, 2005a;Zhao et al., 2007). For this reason, and given that 
CYP158A1 has a very high sequence similarity with CYP158A2 and both produce 
almost identical products by oxidative coupling of flaviolin, CYP158A1 was thought 
to be assuming the role of CYP158A2 in those mutants. Thus, these bacteria would 
have a double mechanism of protection against UV irradiation.
23130
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Figure 8. Confirmation by Southern Blot Hybridisation of the disruption of the gene sco!207 
encoding for CYP158A2. Lane 1-4: Probe: Apramycin resistance disruption cassette (1384 bp). Lane 
5-8: Probe: The gene encoding for CYP158A2 (1212 bp)Lane 1 and 5: ADNA//7/'wdIII marker; lane 2 
and 6: wild type genomic DNA; lane 3: Mutant for CYP158A2 genomic DNA (hybridisation with the 
disruption cassette in the 3300 bp fragment; lane 4: Positive control (apramycin reistance disruption 
cassette); lane 7: Mutant for CYP158A2 genomic DNA (no hybridisation); lane 8: Positive control: 
gene encoding for CYP158A2 (Skaug, 2006).
1.4 FUNCTIONAL GENOMICS
1.4.1 Introduction
In 1989 the first project for sequencing a complete genome was programmed. 
An international consortium was set up in order to sequence the genome of S. 
cerevisiae. In 1995, Haemophilus influenzae was the first living organism to have its 
genome sequenced. Since then, numerous genome sequences from diverse organisms
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have been and are still being published. That sequence of nucleotides contained the 
information of every single aspect of the biology of those living organisms. But it 
needed to be deciphered. The first approaches to do this consisted of figuring out the 
organisation of the genes and their interactions. As new data was being released new 
questions were arising. Transcriptomics, studies on gene expression levels, 
sometimes accompanied by proteomics are still shedding new light on understanding 
the biological processes of living organisms. A new field on functional genomics has 
arisen, as a new approach to try to elucidate the function of genes. This new strategy 
consists of studying the set of metabolites on the cell in a particular moment known 
as the metabolome (Oliver et al, 1998;Tweeddale et a l , 1998).
1.4.2 Studies on metabolome
Functional genomics is the part of genomics which tries to assign function to 
the genes as well as to understand their organization and interactions. Such 
information can be obtained analysing the mRNA transcripts or proteins encoded by 
those genes and also from the set of metabolites of a biological system or 
metabolome (Oliver etal., 1998;Fiehn, 2002).
Metabolomics, or the identification and quantification of all the metabolites 
of a biological system (Fiehn, 2002), emerged at the end of the 90’s as a new strategy 
of functional genomics beside mRNA profiling (transcriptomics) and proteomics 
(Werner et al, 2008). This new approach is important to link gene function to 
phenotype, as it provides detailed measurement of phenotypic responses of living 
organisms to genetic or environmental changes (Kiefer et a l, 2008).
There are a wide array of analytical methods developed to obtain information 
from the metabolome of an organism. These methods range from chromatography 
coupled to mass spectrometry, nuclear magnetic resonance (NMR) or other 
biophysical method such as fourier-transform infrared (FTIR) spectrophotometry. All 
of them are based on the separation and identification of the components of a 
biological sample. Metabolomic experiments usually require the combined use of 
some kind of chromatography with mass spectrometry to achieve high resolution 
results.
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1.4.2.1 Mass Spectrometry
Mass Spectrometry is an analytical technique which identifies the chemical 
composition of a sample based on the mass-to-charge ratio (m/z) of its components. 
(Barker, 1999) It basically involves the ionization of the molecules, separation of the 
ions formed according to the m/z ratio and detection in proportion of their abundance 
in order to produce a mass spectrum which will identify that compound in the 
sample.
The first step is the ionization of the molecules to yield the so called 
molecular ions. This molecular ion normally undergoes fragmentations. The pattern 
of fragmentation provides information concerning the nature and the structure of the 
analyte. The first ionization procedure used was the electron ionization (El) which 
produces an extensive fragmentation of the molecules and covers a narrow mass 
range limiting this technique to small molecules. The ionization techniques have 
evolved since the dawn of Mass Spectrometry to cover the increasing demand of new 
applications such as analysis of biological compounds which have high molecular 
masses. Nowadays, there is a wide variety of other techniques ranging from 
electrospray ionization (ESI) which is used for High Resolution Mass Spectrometry 
and operates by creating a fine spray of highly charged droplets in the presence of an 
electric field, to the Matrix-assisted Laser Desorption Ionisation or MALDI 
technique, which provides more sensitivity minimizing the sample damage, and is 
suitable for proteins, and other biomolecules analyses (Hoffmann and Stroobant, 
2001).
Once the ions have been produced they are separated by their m/z ratio in the 
analyzer. The upper mass limit, the transmission of ions and the resolution are the 
main characteristics of a mass analyzer which have to be considered to choose the 
most appropriate one according to the purpose of the analysis. The procedure in the 
first mass analyzers consisted of separating the ions by accelerating and focusing 
them into a beam. This beam was then subjected to a strong magnetic field 
perpendicular to its direction which produced deflection of the ions. The radius in 
which these ions deflect is inversely proportional to the mass of the ions. Thus, 
lighter ions are deflected more than the heavier ones. However, as the ionization
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sources and techniques have been changing, the mass analyzers had to do so as well 
to meet the demands. Thus, a wide array of mass analyzers is nowadays available 
which perform the separation of ions in many other ways, such as quadrupoles, 
quadrupole ion traps, Time-Of-Flight (TOF) analyzers, or ion cyclotron resonance 
(ICR) analyzers (Barker, 1999;Hoffinann and Stroobant, 2001).
Finally, the ions reach the detector where their abundance is actually detected 
by converting the ion energy into electrical signals which are then transmitted to a 
computer to store and analyse the data.
To summarize, a Mass Spectrometer basically consists of an ion source, a 
mass analyzer, and a detector. All these devices must work under high vacuum. This 
is necessary to avoid unwanted ion collisions with other gaseous molecules which 
produce deviations in the trajectory of the ions, thus complicating the interpretation 
of the spectrum (Hoffmann and Stroobant, 2001).
Application of Mass Spectrometry to biological samples analysis usually 
requires coupling with other analytical techniques such as chromatography to 
separate the compounds to be analyzed first from such complex biological samples. 
Thus, mass spectrometry can be coupled to gas chromatography (GC/MS), liquid 
chromatography (LC/MS) or even to another mass spectrometer in the so-called 
technique Tandem Mass Spectrometry (MS/MS) which consists on at least two mass 
analyzers in series connected by a chamber called the collision cell (Barker, 1999).
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SUMMARY AND OBJECTIVES
The CYPome of S. coelicolor A3 (2) was determined in 2002 (Lamb et al.t 
2002b), and little knowledge still exist about the function of the vast majority of 
those proteins. The elucidation of function can be achieved by the attribution of a 
specific phenotype to a change on the genotype. This approach can be done by 
targeted mutagenesis which requires the fulfilment of directed gene mutations and 
observation of the behaviour and phenotype of those disrupted organisms. This is 
known as functional genomics and makes use of different and diverse techniques in 
order to characterise the mutants.
CYP158A1 and CYP158A2 are two of the 18 CYPs in the CYPome of S. 
coelicolor. These two proteins share high similarity of amino-acid sequence and it 
has been found that they catalyse the same reaction using flaviolin as substrate and 
producing almost identical flaviolin derivatives which are pigments for the protection 
against UV radiation, although by a different mechanism. The deletion of gene 
scol207 encoding for CYP158A2 did not produce the expected change of phenotype 
in the conditions tested. Given their similarity CYP158A1 was thought to be 
substituting CYP158A2 in the production of those pigments, thus suggesting the 
existence of functional redundancy, and this would explain the lack of phenotype.
The aim of this project was to achieve the deletion of the gene sco6998 
encoding for CYP158A1 in a single mutant for that gene, and in a mutant with the 
CYP158A2 gene already deleted to obtain a double mutant for both genes.
Observation of phenotype in the search of accumulation of pigments in the 
mycelium or spores, metabolic profiling by Mass spectrometry of the mutants in 
comparison with the parental phenotype and analysis on the effect of UV radiation in 
the spores survival, were the approaches performed to characterise the mutants 
generated.
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2 MATERIALS AND METHODS
All media and solutions used were autoclaved or filtered with 2 pm of 
diameter filters and every culture or inoculation were set up under a safety cabinet to 
work under sterile conditions.
2.1 ROUTINE PROCEDURES
2.1.1 Transformation of E. coli
The next method was initially described by Hanahan (1983) and allows 
transformation of competent E. coli cells (Sambrook and Russell, 2001).
Competent cells of E. coli ET12567/pUZ8002 are mixed with the cosmid 
containing a fragment of S. coelicolor chromosome with a gene disrupted. 
This mixture is kept on ice for 30 minutes. It is incubated then for 90 seconds 
at 42°C and placed in ice immediately after that for 3 minutes. This heat 
shock is necessary to alter the cell membranes enough to make the DNA 
molecules pass through and into the cell.
- To allow the expression of the antibiotic resistance, 600 pi of expression
medium, LB1 (Lennox Broth), are added to the solution and is incubated with 
agitation at 37°C for 60 minutes. Finally this culture was plated in LB agar 
(2% w/v) plates supplemented with the antibiotic for selection to allow only 
the transformed clones to grow.
2.1.2 Isolation of DNA
Isolation of DNA from bacteria requires the fulfilment of 3 steps: the 
breakage of the bacterial cell wall, lysis of the cell membrane and removal of 
proteins and other contaminants. Different methods exist that use different 
mechanisms and/or reagents to carry out those steps. The choice of a method 
depends on the quantity and the quality of DNA required among other factors.
1 LB (Lennox Broth) Medium: Tryptone (10 g/1), Yeast Extract (5 g/1), NaCl (5 g/1), Glucose (1 g/1)
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The breakage of the cell wall by chemical means is usually achieved by a 
lysozyme treatment. Lysozymes are enzymes that catalyze the acid base hydrolysis 
of linkages between N-acetylglucosamine and N-acetilmuramic acid residues in the 
proteoglycan of bacterial cell walls (Sambrook and Russell, 2001).
The cells can be lysed by chemical treatment with detergents that destroy the 
protein-lipid bilayer of the cell membrane and solubilize transmembrane proteins 
(Alberts et al., 2008). SDS and Triton X I00 are two commonly used detergents.
For the removal of proteins and other contaminants several approaches can be 
followed. Sometimes organic solvents such as phenol, chloroform, and isoamilic acid 
are used to this end. Phenol denatures proteins and when combined with chloroform 
this deproteinisation is more efficient. Thus, the proteins are firstly extracted with 
phenol:chloroform:isoamyl alcohol (25:24:1). The role of the isoamyl alcohol in the 
mixture is the inhibition of RNase activity. A second extraction is then necessary 
with chloroform:isoamyl alcohol to remove any traces of phenol in the sample. 
(Sambrook and Russell, 2001).
Phenol and chloroform are toxic or hazardous organic solvents which require 
special care to handle. Proteinase K is an alternative or sometimes complementary 
method to phenol extraction to remove proteins (Sambrook and Russell, 2001). This 
enzyme degrades most proteins such as RNases, DNases and lysozyme and 
eventually itself (Kieser et a l, 2000).
Once the solution containing DNA has been freed of contaminants, the DNA 
is generally precipitated with ethanol together with a sufficient quantity of cations to 
neutralise the negative charges of the phosphate groups of the DNA that were 
exposed by the alcohol. This amount of cations is usually provided by a solution of 
sodium acetate (Sambrook and Russell, 2001).
23
2.1.2.1 Genomic DNA
Extraction of Streptomyces genomic DNA was carried out by two different 
methods: Salting out procedure from “Practical Streptomyces Genetics” (Kieser et 
al., 2000) and with QIAGEN DNeasy® Blood and Tissue kit.
The Salting out procedure was first described by Pospiech and Neumann 
(1995) and uses proteinase K to lyse the cells and chloroform and a high 
concentration of salts to precipitate proteins and other contaminants.
- Mycelium obtained from 30 ml of an overnight YEME2 culture is suspended 
in 5 ml of SET Buffer3 with 1 mg/ml of lysozyme. The solution is incubated 
at 37°C for 60 minutes.
- Proteinase K (0.5 mg/ml) and 1% SDS are then added and the mixture is
incubated for 2 hours at 55°C to lyse the cells.
- To denature and precipitate proteins 2 ml of 5 M NaCl and, after letting it
cool, 5 ml of chloroform are added to the mixture. Incubation continues for 
30 minutes at room temperature.
- The solution is centrifuged for 15 minutes at 6000 rpm.
- The supernatant is transferred to a new tube where the DNA will precipitate 
after the addition of 0.6 volumes of isopropanol. The precipitated DNA is 
then recovered and wash with 70% v/v ethanol, then dried and finally 
dissolved in TE buffer4.
The QIAGEN DNeasy® Blood and Tissue Kit was used following the 
protocol for gram positive bacteria. The method is based on the selective adsorption 
of DNA to silica-gel membranes.
10 ml of a YEME culture (incubated for around 30 hours) were centrifuged at 
7500 rpm to harvest the cells. The bacterial pellet was resuspended in Enzymatic
2 YEME: Yeast extract (3 g/1), bacto-peptone (5 g/1), mal extract (3 g/1), glucose (10 g/1), sucrose 
(34%), MgCl2-6H20  (5 mM) after autoclaving.
3 SET Buffer: 75mM NaCl, 25mM EDTA pH8, 20mM Tris-HCl pH7.5.
4 TE Buffer: lOmM Tris-HCl, ImM EDTA.
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Lysis Buffer5 and incubated for 1 hour at 37°C. The rest of the protocol can be found 
in the DNeasy® Blood and Tissue Handbook. This kit uses proteinase K as well to 
lyse the cells.
2.1.2.2 Plasmid DNA
2.1.2.2.1 Alkaline Lysis
Plasmid and cosmid DNA from E. coli was isolated by alkaline lysis 
following the protocol described by Sambrook et al (2001) slightly modified.
- A single colony of E. coli carrying the plasmid to be isolated is inoculated in 
10 ml of LB medium1 supplied with the antibiotics to which the plasmid 
provides resistance. This pre-culture is left incubating at 37°C with shaking 
overnight.
30 ml of LB with antibiotics were inoculated with 100 pi of that pre-culture 
and incubated overnight at 37°C with shaking.
- The culture is then centrifuged to harvest the cells and the pellet is suspended 
in 5 ml of Alkaline Lysis Solution I6. This mixture is incubated for 5 minutes 
at room temperature.
10 ml of freshly prepared Solution n 7 are then added and the mixture is 
incubated in ice for 10 minutes.
- 7.5 ml of ice-cold Solution HI8 are added and the mixture is incubated in ice 
for another 10 minutes.
- After centrifugation at 7000 rpm for 40 minutes at 4°C the supernatant is 
recovered and filtered by passing it through a 5 ml micropipette tip with a 
ball of cotton on the bottom.
- 0.6 volumes of isopropanol are then added to the filtered solution and is 
incubated for 15 minutes at room temperature to precipitate DNA. The 
solution is then centrifuged, the pellet washed with 70% v/v ethanol and then 
resuspended in 500 pi of TE Buffer.
- The DNA is then treated with 40pg/ml RNAse for 30 minutes at 37°C.
5 Enzymatic Lysis Buffer: 20mM Tris-HCl pH8, 2mM sodiumEDTA, 1.2% Triton X100, 20 mg/ml 
lysozyme.
Alkaline Lysis Solution I: 50mM Glucose, 25 mM Tris-HCl pH 8,10 mM EDTA, 5mg/ml lysozyme.
7 Alkaline Lysis Solution II: 0.2 N  NaOH, 1% SDS.
8 Alkaline Lysis Solution III: 3 M Potassium acetate, 5 M Glacial Acetic Acid, pH4.8
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- After that the DNA solution is phenolised to remove all the proteins. 1 
volume of phenol:chloroform:isoamyl alcohol (25:24:1) is added to the 
solution, and after centrifugation the superior phase is recovered in a new 
tube where chloroform:isoamyl alcohol is added to remove any rest of 
phenol.
- After centrifugation the DNA solution free of contaminants is precipitated
with 1 ml of 100% v/v ethanol (kept at -20°C) and 50 pi of 3M sodium
acetate and left at -20°C overnight.
- The next day the solution is centrifuged and the pellet washed with 70% v/v 
ethanol. The pellet is dried and finally resuspended in 100 pi of TE Buffer.
2.1.2.2.2 Minipreparations of plasmid DNA
Small quantity of DNA was isolated for the selection of clones after 
transformation of E. coli following this protocol based on the one described by 
Holmes and Quigley in 1981 (Holmes and Quigley, 1981).
- A single colony of E. coli is inoculated in 1 ml of TB medium supplied with
the antibiotic for selection. The culture is incubated overnight at 37°C with
agitation.
- After centrifugation for 4 minutes at 8000 rpm the cells are recovered and 
resuspended in 350 pi of STET buffer9. 10 pi of Lysozyme (10 mg/ml) are 
then added and the solution is incubated for 45 seconds with intense agitation.
- Immediately after, the solution is incubated in boiling water for 45 seconds. 
This treatment denatures chromosomal DNA and proteins which precipitate 
after centrifugation for 15 minutes at 14000 rpm. They are easily removable 
from the bottom of the tubes with a sterile tooth pick.
1/10 of the volume of 3M sodium acetate and 1 volume of isopropanol are 
added to the supernatant obtained to precipitate DNA. After 10 minutes the 
solution is centrifuged for another 10 minutes and the supernatant is 
discarded.
- The DNA precipitated is washed with 70% v/v ethanol, dried and suspended 
in 30 pi of TE buffer.
9 STET Buffer: 8% Sucrose, 0.5% Triton XI00, EDTA 50mM lOmM Tris-HCl,, pH8.
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2.1.3 Quantificati on of DNA
The purified DNA was quantified by spectrophotometry with a Nanodrop™ 
1000 Spectrophotometer (ThermoScientific). This is a fast, reproducible and clean 
way to quantify DNA and it only requires 2 pi of sample.
2.1.4 Gel Electrophoresis
All gel electrophoresis were carried out using 0.8% w/v agarose gels. The 
gels were stained with SYBR® Safe to manifest the DNA bands. 1 pi of SYBR safe 
was added to each 10 ml of agarose gel buffer (IX TAE10) with 0.8% w/v of agarose, 
when the latter was dissolved on the buffer and before being casted. The samples 
were run through the gel using IX TAE and 90 V of voltage.
2.1.5 PCR reactions
All PCR reactions were done using the thermostable enzyme Taq DNA 
Polymerase. The program used for these reactions was the following:
- First denaturation step: 96°C for 4 minutes
- 33 cycles
o Denaturation: 96°C, 30 seconds 
o Annealing: 68°C, 45 seconds 
o Polymerisation: 72°C, 1 minute 45 seconds
- Final extension: 72°C, 4 minutes
Taq DNA Polymerase from Invitrogen and GoTaq® from Promega were used 
indistinctively. DMSO (dimethyl sulfoxide) was used in every reaction as enhancing 
agent (10% of the reaction volume). This agent facilitates strand separation 
disrupting base pairing.
10 IX TAE (Tris-Acetate:EDTA): 20 ml of 50X TAE in 11 of deionised water (50X TAE: 242 g/1 Tris 
base, 57.1 ml/1 glacial acetic acid, 100 ml/10.5 M Na2 EDTA pH 8.0).
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2.1.6 Restriction Enzyme Digestions
Every digestion reaction was carried out using 10 % of the appropriate 
restriction buffer recommended by the manufacturer for each enzyme, at 37°C, for 2 
hours.
2.2 MANIPULATION OF S. coelicolor A3(2)
2.2.1 Media
Streptomyces have a complex life cycle involving the production of typically 
fungal aerial and substrate mycelia. They produce spores in the last steps of their life 
cycle as a mean to disperse. The choice of the media to use for their manipulation has 
to be done according to these characteristics.
MS medium11 (Mannitol soya flour medium, first described by Hobbs et al. 
(1989) (Kieser et a l, 2000) was the solid medium used to culture S. coelicolor. This 
medium allows good sporulation. Plates were incubated at 30°C.
Cultures in liquid medium were done with YEME medium (Yeast Extract- 
Malt Extract Medium). It contains a high amount of sucrose (340 g/1) to allow 
dispersed growth of the mycelium in the medium avoiding production of compact 
masses commonly produced by some Streptomyces species (Kieser et a l, 2000). The 
flasks were incubated with agitation, which assists as well on the avoidance of 
mycelium lumps production, at 30°C.
2.2.2 Recovery of Spores
Spores were recovered from MS plates incubated for one week using a 
solution of 0.025% v/v Triton XI00.
2 ml of 0.025% v/v Triton XI00 were added to the plates, and spores were 
gently scraped with a sterile cotton bud to avoid lumps of agar medium given that S. 
coelicolor is an agarolytic microorganism (Kieser et a l, 2000). The suspension is
11 MS, Mannitol-Soya Flour Medium: Mannitol 20 g/1, Soya Flour 20 g/1, Agar 20 g/1
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recovered in eppendorf tubes and centrifuge in a microcentrifuge. The pellet is 
washed with 1 ml of the same solution of Triton X I00. After another centrifugation 
the resultant pellet is resuspended in a solution with 30% v/v glycerol and 0.025% 
v/v Triton X100. Spores are conserved at -80°C. Some suspensions are kept at -20°C 
to use frequently as inoculum for culturing.
2.3 REDIRECT
Targeted mutagenesis for gene replacement was carried out following the 
method REDIRECT (Gust et al., 2002). This PCR-based methodology consists of the 
replacement of a gene by the introduction of a disrupted cosmid in Streptomyces by 
conjugation from E. coli.
A disruption cassette containing a selectable marker 
(spectinomycin/streptomycin resistance gene) and an oriT region (to allow its 
transfer to S. coelicolor) is constructed and amplified by PCR, using specific primers 
which will introduce a sequence matching the zone adjacent to the gene to be 
deleted. This gene is then replaced by the spectinomycin/streptomycin cassette by 
recombination in the cosmid 8F11 carrying the gene for the CYP158A1. This 
replacement is possible introducing both the cosmid and the cassette into an 
appropriate host providing a high rate of recombination such as E. coli BW25113 
carrying the plasmid pD790. The disrupted cosmid is cloned into a methylation 
deficient E. coli host such as ET12567 carrying the non-transmissible plasmid 
pUZ8002. S. coelicolor has a powerful methylation-restriction system which would 
degrade any external DNA that is introduced in the bacterium. This is solved by 
passaging the cosmid through this non-methylation E. coli strain. Given that the 
cosmid has an oriT region, can be transferred to S. coelicolor then by conjugation, 
and recombination of the cassette with the chromosome will lead to the desired gene 
deletion.
The strain E. coli BW25113/pU790 transformed with the cosmid 8F11 
containing a fragment of S. coelicolor chromosome with a gene disrupted and E. coli 
ET12567/pUZ8002 transformed with that disrupted cosmid were accomplished and
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provided for this work by Dr. Colin Jackson. The CYP158A2 mutant was previously 
achieved by Dr. Tove Skaug in this laboratory.
2.3.1 Purification of the PCR template
Spectinomycin cassette was obtained from the plasmid pIJ778 (Figure 9). 
This cassette consists of the streptomycin and spectinomycin resistance gene aadA, 
and the oriT of plasmid RP4 flanked by FRT sites (FLP recombinase recognition 
sites). It was cloned into the EcoRV site of pBlueScript KS(+) obtaining the plasmid 
pIJ778. The cassette is flanked by EcoRUHincfUl sites that allow its isolation from 
the plasmid.
pi J778
4377 bp*
Figure 9. pIJ778. (Gust et al., 2002)
In order to use this cassette as PCR template, it is necessary to isolate it from 
the plasmid to avoid a high proportion of false positive transformants (antibiotic 
resistant but without gene disruption transformants) that would be obtained working 
with the whole plasmid as a template, because of traces of covalently closed circular 
DNA (CCC) competing with linear PCR fragments. Therefore, the plasmid was 
digested with the restriction enzymes EcoRl and HintSBL, and the fragment of 1425 
bp corresponding to the spectinomycin cassette was purified from a 0.8% agarose gel 
band. The template for the PCR amplification is shown in figure 10.
FRT oriT aadA FRT
I tU  « 0-1 I
EcoRI H ind i II
Figure 10. Spectinomycin/streptomycin disruption cassette. Isolated from the plasmid pIJ778.
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2.3.2 Design of primers for PCR amplification of the 
spectinomycin/streptomycin disruption cassette.
Specific pnmers were designed and used for the PCR amplification. These 
pnmers have 19 or 20 nucleotides at the 3’ end which match the end of the disruption 
cassette, and 39 nucleotides at the 5’ end matching the sequence adjacent to the gene 
to be deleted (158A1). Thus, the amplified cassette is able to recombine with the 
chromosomal DNA of S. coelicolor to obtain the desired deletion (figure 11).
sco6998
FRTFRT oriT aadA
FRT
1 a; 1 NNNNN)
FRT oriT aadA
1NNNNN ATGT
Figure 11. a) Gene sco6998 encoding the CYP158A1. b) Design of primers. The 3’ end of each 
primer matches the right or left end of the disruption cassette, in each case. The 5’ end has the same 
sequence than the ends of the gene, c) Amplification product after PCR.
2.3.3 Disruption of the CYP158A1 encoding gene in the cosmid 8F11.
The disrupted cosmid, which was provided by Colin Jackson, carrying the 
spectinomycin cassette instead of the gene, was produced by recombination of the 
resistance cassette with the cosmid 8F11 carrying the CYP158A1 gene sco6998. This 
cosmid 8F11 is a Supercos 1-denved cosmid and contains a resistance gene for 
ampicillin.
In order to do so, both cassette and cosmid were introduced in a host which 
allowed high rate of recombination. This host was E. coli BW25113 carrying the 
plasmid pIJ790 which is a lambda-RED recombination plasmid containing the 
lambda bacteriophage genes gam, exo and bet.
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Due to the presence of recBCD exonuclease DNA repair system, which 
destroys any invading linear DNA, many bacteria are not easily transformable with 
linear DNA. These three genes gam, exo and bet from lambda bacteriophage, encode 
for proteins which help to promote recombination between the viral DNA and the 
chromosomal DNA when the bacteriophage infects a bacterium. One of them, the 
product of gene gam, binds to the exonuclease V of the system recBCD blocking it, 
and avoiding the degradation of the viral DNA. The products of genes exo and bet 
help to the formation of the recombination complex. Therefore, the presence of this 
A-RED plasmid containing those genes provides high rate of recombination using 
linear DNA (Datsenko and Wanner, 2000;Gust et a l, 2004).
2.3.3.1 Introduction of the cosmid and the cassette into E. coli 
BW25113/pIJ790 by electroporation
The cosmid 8F11 and the spectinomycin cassette were introduced into E. coli 
BW25113/pU790 by electroporation. This method of bacterial transformation 
consists of the application of an electrical discharge to the cells destabilizing the cell 
membrane and producing small pores which allows the introduction of genetic 
material inside them (Sambrook and Russell, 2001).
The procedure starts growing the cells (E. coli BW25113/pU790) overnight at 
30°C in LB medium12 containing chloramphenicol (25 pg/ml) to select for the pU790 
(which contains the chloramphenicol resistance gene cat). 100 pi of this culture are 
used to inoculate 10 ml of SOB13 medium containing 20mM MgSC>4 and 
chloramphenicol (25 pg/ml). After 3-4 hours of shaking incubation at 30°C, the cells 
are centrifuged and the pellet is resuspended in 10% v/v glycerol. 50 pi of this 
suspension were mixed with the DNA to be inserted (cosmid 8F11 DNA firstly) and 
electroporation was carried out. Immediately after that 1 ml of ice cold LB was 
added to the shocked cells and were left incubating for an hour. This culture was 
plated in LB agar containing the selection antibiotics (100 pg/ml ampicillin, 50 
pg/ml kanamycin and 25 pg/ml chloramphenicol). Positive transformants were
12 LB Medium: Tryptone (10g/l), Yeast Extract (5g/l), NaCl (5g/l), Glucose (lg/1).
13 SOB Medium: Tryptone (20g/l), Yeast Extract (5g/l), NaCl (0.5 g/1), 1M KC1 (2.5ml/l). After 
autoclaving 10 ml of 1M MgCl2 are added to the medium.
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selected after incubation overnight depending on the ampicillin (encoded in the 
cosmid) and chloramphenicol (encoded in the plasmid pU790) resistance.
After amplifying it by PCR with the designed primers, the spectinomycin 
cassette was as well introduced into E. coli BW25113/pU790 carrying as well the 
8F11 cosmid by electroporation following the same procedure. After the electrical 
shock 1 ml of LB medium was added to the cells and incubated for an hour at 37 °C, 
instead that at 30°C, to promote the loss of pU790. When plating this culture in LB 
agar plates, the antibiotics used for the posterior selection of positive transformants 
were ampicillin, kanamycin and spectinomycin (100 pg/ml).
Homologous recombination is then expected to occur between the cosmid 
and the cassette. The extended cassette was constructed so that its ends match the 
sequence adjacent to the CYP158A1 gene in the cosmid, so recombination is 
possible between both. This homologous recombination does not occur in all the 
copies of the cosmid molecules in one cell, therefore there will be clones with both 
wild type and mutant cosmids (one copy of the mutagenised cosmid is sufficient to 
provide resistance). To select the positive transformants with the mutagenised 
cosmid, a colony was isolated inoculating it in LB with the selection antibiotics and 
incubated for 6 hours. At this time the cosmid DNA was isolated and tested by 
restriction analysis and PCR.
2.3.3.2 Transfer of the mutant cosmids into S. coelicolor by conjugation.
Intergeneric conjugation is a simple way to transfer genetic material from E. 
coli to Streptomyces. This procedure requires the presence of vectors containing an 
oriT and transfer genes which are provided by the E. coli host (Kieser et al, 2000). 
In our case this vector is E. coli ET12567 carrying the plasmid pUZ8002.
S. coelicolor carries a methyl-sensing restriction system which would degrade 
any external DNA that is intended to introduce in it. To avoid this, intergeneric 
conjugation is carried out between the non-methylating E. coli strain ET12567 with 
the plasmid pUZ8002 and S. coelicolor. The plasmid pUZ8002 contains a kanamycin 
resistance gene and lacks a cis-acting function for its own transfer.
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Conjugation was carried out between E. coli ET12567/pUZ8002 and S. 
coelicolor to obtain mutants with the gene sco6998 encoding for CYP158A1 deleted 
A wild type strain was conjugated with this E. coli strain to obtain a single mutant for 
this gene, and in parallel, a S. coelicolor mutant with a deletion on the gene scol207 
encoding for CYP158A2 was conjugated as well to obtain a double mutant with both 
genes deleted.
23.3.2.1 Conjugation between E. coli ET12567/pUZ8002 containing the 
disrupted cosmid and S. coelicolor
The cosmid containing a spectinomycin/streptomycin resistance construct 
with the flanking DNA of the gene sco6998 (CYP158A1) was introduced into 
competent cells oiE. coli ET12567/pUZ8002 by transformation.
The transfer of the disrupted cosmid from E. coli ET12567/pUZ8002 to S. 
coelicolor by conjugation was achieved mixing heat-shocked spores of S. coelicolor 
with a cell suspension of the E. coli strain. Spores of the wild type were used to 
obtain the single mutant and spores from a mutant with the gene scol207 encoding 
for CYP previously deleted were used to obtain the double mutant. The procedure is 
detailed above.
- A pre-culture of E. coli ET12567 was prepared inoculating 100 pi of E. coli 
ET12567/pUZ8002 containing the gene knock-out cosmid in 10 ml of LB medium 
containing spectinomycin (100 pg/ml), chloramphenicol (50 pg/ml) and kanamycin 
(50 pg/ml). This pre-culture was incubated overnight at 37°C.
- 7 ml from this overnight culture were inoculated into 30 ml of LB with 
antibiotics (spectinomycin, chloramphenicol and kanamycin as above) and grown for 
4-5 hours at 37°C to an ODeoo of 0.4. The cells were then washed twice with LB to 
remove any remaining antibiotics, by centrifuging them at 5000 rpm for 10 minutes, 
and then were resuspended in 3 ml of LB medium.
- While washing the E. coli cells, 5 pi of S. coelicolor spores were added to 
500 pi of 2XYT broth. Heat shock was performed to these spores at 50° C for 10 
minutes.
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- 0.5 ml of the heat-shocked spores were mixed with 0.5 ml of E. coli cell 
suspension. After centrifugation, most of the supernatant is discarded and the cell 
pellet is resuspended in the 50 pi residual liquid. Dilution series were made from 10'1 
to 10'4 in a total of 100 pi, and were plated in MS agar plates with lOmM MgCh and 
incubated at 30°C for 16-20 hours.
- The next day, the plates were overlaid with 1 ml of water containing 0.5 mg 
nalidixic acid (which selectively kills E. coli) and 5 mg of spectinomycin. The 
incubation was continued at 30° C for about a week.
The same procedure was made to replace the gene encoding for CYP158A1 
in the wild type strain to obtain the single mutant and in the mutant containing a 
deleted scol207 (encoding for CYP158A2) in order to obtain a CYP158A1 and 
CYP158A2 double mutant to compare to the existing strains.
2.3.3.2.2 Screening for double cross-over exconjugants
During recombination between the disrupted cosmid and the chromosome of 
S. coelicolor a single or a double cross-over can occur. When a single cross-over 
happens the cassette and the rest of the cosmid are inserted in the chromosome thus 
providing resistance to antibiotic encoded by the cosmid and to spectinomycin. The 
replacement of the gene is not successful if this occurs. Double cross-over ex­
conjugants, however, have the cassette inserted in the chromosome replacing the 
gene and are only spectinomycin resistant (Figure 12).
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k /o  8F11
Spectinomycin cast
k /o  8F11
S p e c tlt
F i g u r e  1 2 .  R e c o m b i n a t i o n  b e t w e e n  t h e  d i s r u p t e d  c o s m i d  ( k / o  8 F 1 1 )  a n d  t h e  c h r o m o s o m e  o f  S.
coelicolor. The ampicillin resistance gene encoded in the plasmid is shown as ampR (in purple) 
a )  Single cross-over. Insertion of the cassette and the cosmid. The gene remains in the chromosome, 
b )  Double cross-over. Replacement of the gene sco6998 by the spectinomycin cassette.
The colonies that grew after a week in MS plates with the overlay of 
spectinomycin were replica-plate in MS plates containing nalidixic acid and 
spectinomycin with and without ampicillin (100 pg/ml). Ampicillin sensitive clones 
were streaked for single colonies on MS agar containing nalidixic acid (25pg/ml) and 
spectinomycin (100 pg/ml). The same procedure was repeated again to confirm 
ampicillin sensitivity: Single colonies were replica-plate in MS with nalidixic acid 
and spectinomycin with and without ampicillin. The confirmed ampicillin sensitive 
strains are then venfied by PCR, Southern Blot analysis and DNA sequencing.
2.4 SOUTHERN HYBRIDISATION
Gene replacement was attempted to be corroborated by Southern 
blottmg/hybndisation. This technique consists of the hybridisation of a (labelled) 
specific probe with the genomic DNA of the wild type strain and the mutants. For 
this purpose the DNA is digested with an appropriate restriction enzyme and 
separated by gel electrophoresis. DNA is then transferred from the gel to a nylon 
membrane. Two different probes were used and therefore two different membranes, 
each one exposed to one of the probes. One of the probes was the gene sco699%
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encoding for the CYP158A1 and the other one was the spectinomycin cassette from 
the plasmid pU778.
2.4.1 Labelling of probes
The two probes used to hybridise with the genomic DNA were the gene 
encoding for the CYP158A1 and the spectinomycin cassette to allow total 
complementarity between the probe and the target DNA. They were obtained by 
standard PCR using specific primers. The location of each primer is shown in figure 
13.
Both probes were labelled with digoxigenin (DIG) by random primed DNA 
labelling using the DIG High Prime DNA Labelling and Detection kit I (Roche). 
Digoxigenin is joined to dUTP and acts as the antigen for the antibody anti- 
digoxigenin. This random priming consists of the random annealing of a mixture of 
hexanucleotides, which would be the primers, with the probe DNA previously 
denatured. The klenow fragment of the DNA polymerase I from E. coli synthesizes 
then new DNA from the 3’ end of the primers incorporating those dUTP DIG- 
conjugated. The DIG-High Prime system was the method followed to label the 
probes.
16 pi of DNA (about 1 pg) were denatured by heating in boiling water for 10 
minutes and cooling immediately afterwards on ice. 4 pi of labelling solution (DIG- 
High Prime) were then added containing hexanucleotides mixture, DIG labelled 
DNA and Klenow enzyme. The reaction was incubated at 37°C overnight. The 
labelling reaction was stopped by adding 2 pi of 0.2M EDTA (pH 8).
2.4.2 Digestion and separation of genomic DNA
The genomic DNA of both wild type strain and the mutants was digested and 
separated by gel electrophoresis. The appropriate restriction enzyme to use must not 
cut inside the gene or the cassette. In figure 6 the restriction map of the gene and the 
cassette for the enzymes Apal and BamHl is shown. Restriction analysis was done 
using the online software tool Watcut, University of Waterloo, Ontario, Canada, 
(http://watcut.uwaterloo.ca/watcut/watcut/template.php).
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Apal was an appropriate enzyme to use since does not cut inside the gene nor 
the cassette. This enzyme provides a restriction fragment of 1783 bp which includes 
the whole gene and a fragment of 1984 when the cassette is inserted on the 
chromosome.
The enzyme BamHl was as well used in several experiments. It cuts inside 
the gene producing two different fragments, of 1720 and 2062 bp. None of this 
fragments contains the whole gene. The spectinomycin/streptomycin disruption 
cassette has a recognition site for BamHl at one of its ends. When this cassette is 
inserted in the chromosome replacing the gene, digestion with BamHl produces a 
fragment of 3059 bp. The size of the DNA fragment produced with this enzyme if 
there was no cut inside the cassette would be 3983 bp.
a
BamHl Apa I sco6998 Bam  HI Apa I BamHl
C assette BamHl
*t>—
BamHl Apa  I BamHl Apa\ BamHl
F i g u r e  1 3 .  R e s t r i c t i o n  m a p  o f  t h e  g e n e  sco6998 a n d  t h e  s p e c t i n o m y c i n  c a s s e t t e  f o r  t h e  e n z y m e s  
Apal  a n d  BamHl. a )  Apal produces two cuts flanking the gene producing a fragment of 1783 bp. It 
does not cut inside the cassette. BamHl cuts inside the gene producing two fragments, of 1720 and 
2062 bp. None of them contains the whole gene. It also cuts inside the cassette, b )  When the cassette 
is inserted in the chromosome, digestion with Apal yields a fragment of 1984 bp containing the 
cassette. BamHl produces a fragment of 3046 bp when it cuts at the end of the cassette. If that 
recognition site was not there the restriction fragment would be 3983 bp.
Digestion was carried out overnight. The electrophoresis was carried out at 
60 V for 2 hours. Two digestion reactions were done for each sample and the two 
batches were subjected to gel electrophoresis separately and transferred each one to a 
different membrane to hybridize with the two probes.
38
2.4.3 Capillary transfer
Once the DNA was separated by electrophoresis, the gel was subjected to 
several treatments to allow the transfer of the DNA to the membrane.
First of all, DNA was partially depurinated by controlled acid treatment with 
hydrochloric acid (250 mM HC1) for 10 minutes at room temperature and shaking. 
This step, however, is sometimes not necessary or even counterproductive, as the 
DNA can be cleaved in very small fragments that are too short to bind efficiently to 
the membrane (Sambrook and Russell, 2001). Therefore, both approaches were 
tested to see which one provided better results.
The DNA was then denatured by submerging it for 15 minutes at room 
temperature in alkaline denaturation solution14 which makes DNA to break in the 
depurinated sites. Finally, the gel is submerged in Neutralisation buffer15 for 15 
minutes at room temperature and shaking. This neutralisation treatment is necessary 
to lower the pH of the gel so that the DNA can bind to the membrane.
The capillary blot was then constructed to proceed with the transfer. The gel 
was placed inside a recipient filled with 500 ml of 10X SSC (Sodium chloride 
Sodium Citrate) on an inverted plastic box. Salt concentration is an important factor 
in the retention of DNA by the membrane. At a concentration of 1 OX SSC DNA is 
almost completely retained (Southern, 1975). A piece of filter paper is placed behind 
the gel in contact with the SSC in the recipient at both sides so that the liquid will go 
through the blot by capillarity. The nylon membrane (Hybond-N, Amersham) was 
placed in contact with the membrane and above it several layers of filter and 
absorbent paper. A weight was placed on the top to help the transfer (figure 14). The 
blot was left overnight for the DNA to transfer to the membrane. Once the entire 
DNA was transferred, which was confirmed as there was no loading dye left in the 
gel, the DNA is fixed onto the membrane by UV-crosslinking. This fixation consists 
of the formation of a covalent bond between the amino group of the nylon of the 
membrane and the thymine of the DNA. Right after dismantling the blot, the
14 Denaturation Solution: 0.5M NaOH, 1.5M NaCl
15 Neutralisation Solution: 3MNaCl, 1.5 TrisHCl
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membrane was dried at room temperature in a flat surface and then placed in an UV- 
Crosslinker (HL 2000 Hybrilinker, UVP laboratory products).
>  W eight Absorbent Paper
Filter Paper (3 layers)
M em brane
Gel
Filter Paper
10x SSC
Figure 14. Southern Blot.
2.4.4 Hybridisation
Hybridisation was earned out in two different hybridisation tubes each of 
them carrying the membrane to be hybridised with its correspondent probe. A 
prehybndisation step was necessary to avoid non-specific binding blocking the zones 
of the membrane where there was not DNA.
The prehybridisation buffer16 was prepared adding 1 g of blocking reagent 
(Roche) per 100 ml of solution. The membranes were inserted in a hybridization tube 
and prehybridisation was performed in a HL-2000 Hybrilinker hybndiser (UVP). 
Different temperatures and therefore different hybndisation times were tested: 68°C 
for 2 hours and 65°C for 3 hours. After this time the prehybndisation buffer was 
discarded and the hybridisation buffer was prepared adding the probes (previously 
denatured by heating in boiling water for 10 minutes and chilling it afterwards on 
ice) to the prehybndisation buffer. The membranes were left hybndising overnight at 
the prehybridisation temperature.
16 Pre/Hybridisation Buffer: 5x SSC, 0.1% laurylsarcosine, 0.02%SDS, blocking reagent 1%
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2.4.5 Stringency washes and detection
After hybridisation the membranes were washed to remove the unbound 
probe. The membranes were incubated in Stringency Wash Solution I17 for 15 
minutes at room temperature, two times, and after that in Stringency Wash II18 once, 
for 15 minutes at room temperature.
The detection of the labelled probes was carried out by colorimetric detection 
by enzyme immunoassay. The membranes were incubated with an antibody anti-DIG 
which is conjugated with alkaline phosphatase. This enzyme uses NBT/BCIP (Nitro 
blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate) as substrate to yield a 
purple precipitate.
After the stringency washes the membranes were equilibrated for 1 minute in 
washing buffer19. The zones of the membrane where there was no probe were 
blocked by adding 30 ml of blocking solution20 and incubating for 30 minutes. The 
membranes were then exposed to the antibody solution21 for another 30 minutes at 
room temperature. To remove the unbound antibody, the membranes were washed 
twice with washing buffer for 15 minutes and then equilibrated in detection buffer22 
for 5 minutes.
The colorimetric detection was carried out adding 200 pi of NBT/BCIP to 10 
ml of detection buffer and incubating the membranes in that solution overnight in the 
dark. After around 12 hours, the purple precipitate was evident and the membranes 
were dipped briefly in distilled water to stop the reaction.
17 Stringency Wash I (2x): 2x SSC, 0.1% SDS
18 Stringency Wash II (0.5x): 0.5x SSC, 0.1%SDS
19 Washing Buffer: 0.3% Tween 20 in Maleic Acid Buffer (0.1M Maleic Acid, 0.15MNaCl)
20 Blocking Solution: 1 % Blocking Reagent [Roche] in Maleic Acid Buffer
21 Antibody Solution: 1:3000 antibody in blocking buffer
22 Detection Buffer: 0 .1M TrisHCl, 0 .1M NaCl
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2.5 VERIFICATION OF THE MUTANTS BY PCR
PCR analyses were earned out in order to corroborate the insertion of the 
cassette in the genome of S. coelicolor and therefore the deletion of the gene sco6998 
encoding for CYP158A1. The position of the primers used for these analyses is 
shown in figure 15 and their sequences in table 1, annexe 2. All calculations were 
made according to published sequences deposited in GenBank® 
(http://www.ncbi.nlm.nih.gov/Genbank/index.htmn.
SpmCssF
Spectinomycin Cassette (1424 bp)
SpmCssR
158A1conF1
158A1conR1
F i g u r e  1 5 .  L o c a t i o n  o f  p r i m e r s  f o r  t h e  a m p l i f i c a t i o n  o f  t h e  g e n e  a n d  t h e  c a s s e t t e .  Primers are 
shown as red arrows. The internal test primer for the spectinomycin cassette is indicated in green a )  
Spectinomycin cassette b)CYP158Al gene.
Three different PCR reactions were done with different primers. Primers for 
the amplification of the gene and the cassette as well as an internal primer for the 
spectinomycin cassette were used to manifest their presence or absence.
The forward pnmer for the amplification of the gene sco6998 (1223 bp) 
encoding the CYP158A1 (158AlconFl) anneals 202 bp downstream the end of the 
gene and the reverse pnmer (158AlconRl) anneals 225 bp upstream the other end 
(see figure 15). Thus, the PCR reaction using these primers will yield a fragment of 
1650 bp. When the spectinomycin cassette (1424 bp) is inserted replacing the gene 
the amplification product will be 1851 bp long. Primers for the amplification of the 
cassette anneal 58 bp (forward, SpmCssF) and 45 bp (reverse, SpmCssR) from each 
end of the cassette, therefore the product obtained from this PCR reaction will be 
1327 bp.
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The other PCR reaction was done with a primer annealing inside the 
spectinomycin cassette. This primer (SpecIntF) which anneals 602 bp from the end 
of the cassette and the reverse primer for the gene will yield a product of 827 bp. The 
presence of that DNA fragment would confirm the presence of the spectinomycin 
cassette.
To sum up, the insertion of the spectinomycin cassette in the locus of the 
gene sco6998 will be confirmed by PCR if there is DNA amplification when using 
primers annealing at both ends of the spectinomycin cassette or inside, and if the 
amplification product obtained using flanking primers for the CYP158A1 gene 
(sco6998) is 1851 bp long, corresponding to the inserted spectinomycin cassette.
2.6 SEQUENCING
Diagnostic DNA sequencing of the mutants was carried out in order to try a 
different approach to confirm the insertion of the cassette. The sequence obtained 
was compared with the sequence of the gene (and adjacent zones of the 
chromosome) and with the spectinomycin cassette. These sequences were found in 
GenBank® database.
Two PCR reactions using internal primers for the spectinomycin resistance 
and flanking primers for sco6998 (CYP158A1 encoding gene) were undertaken. 
DNA was isolated from 0.8% agarose gels using the QIAquick® Gel Extraction Kit 
(QIAGEN). The purified DNA was quantified by spectrophotometry with a 
Nanodrop™ 1000 Spectrophotometer (ThermoScientific). Approximately 150 ng of 
DNA in solution were dried in a vacuum concentrator (Concentrator 5301, 
Eppendorf).
The samples were sent for analysis by Eurofins MWG Operon. An automated 
sequencing method was used based on chain termination sequencing method, also 
known as Sanger sequencing, using fluorescence labelled dideoxynucleotides.
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2.7 STUDIES ON PHENOTYPE OF THE MUTANTS COMPARED TO 
THE PARENTAL STRAIN
Disruption of the biosynthetic pathway of flaviolin derivatives by deletion of 
the gene encoding for the CYP158A1 in a deletion mutant for CYP158A2 (double 
mutant) would lead to the accumulation of flaviolin which is the substrate of the 
enzyme. Theoretically, this would not happen to the single mutants for CYP158A1 
as they still have CYP158A2 working and coupling flaviolins.
Flaviolin is a red-brown pigment. Previous studies in S. griseus showed that 
the mycelium and spores from a mutant with a deletion in the CYP158A1 
homologous P450mel gene were red, unlike the wild type’s (Funa et al., 2005a;Funa 
et a l, 2005b).
In order to detect any phenotypical change on the mycelium or spores of the 
mutants, cultures in solid (MS) and liquid (YEME) medium were set for the 
CYP158A1 mutant, CYP158A2 mutant and the double mutant with both genes 
deleted.
MS plates were incubated at 30°C for 7 days and observed every day for any 
change on the phenotype.
30 ml YEME cultures were set at 30°C and incubated for 5 days, checking 
the flasks every day.
2.8 UV EFFECT ON SPORE SURVIVAL
Flaviolin dimers and trimers are pigments that may protect S. coelicolor 
against UV irradiation (Zhao et al., 2005). Given this, and since the mutants would 
have the biosynthesis pathway for that pigments interrupted, spores of the wild type 
and mutants were exposed to short wavelength UV light to test the effect on their 
survival.
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The protocol followed for this UV effect analysis was the one previously 
described by Funa et al. (Zhao et a l, 2005). Approximately 108 spores of the wild 
type and the mutants were suspended in 20 ml of 10% glycerol and then irradiated 
with 254 nm UV light at a distance of 30 cm at different times. A Mineralight® 
ultraviolet lamp (UVP) was used for the experiment. 0.1 ml of an appropriate 
dilution of that UV-irradiated spores were plated in R5 medium23 and incubated for 2 
days. The colonies were then counted and the spore survival was calculated as the 
ratio between the number of colonies that appeared under UV irradiation with respect 
to the colonies appeared without UV treatment.
Irradiation and plating was carried out in dull light although this was not 
necessary given that S. coelicolor A3 (2) cannot accomplish photoreactivation 
(Harold and Hopwood, 1970;Clarke and Hopwood, 1976). A search in StrepDB 
(Streptomyces annotation server, http://strendb.streptomvces.ore.vk) and GeneBank® 
database reveals that S. coelicolor genome contains 3 genes encoding for putative 
photolyases (sco0842, sco0183 and sco0184). However, it has been reported that this 
organism does not show photolyase activity (Mayerl etal,  1990).
2.9 METABOLIC PROFILING
2.9.1 Method of extraction
5 ml of a 4 days culture in YEME medium were harvested and its pH 
adjusted to 5-6 with 1M HC1 or sodium bicarbonate (NaHCOs) when necessary. The 
metabolites were extracted with an equal volume of ethyl acetate (0.5% v/v ethanol) 
for three times. The three extracted solutions were combined and dried with Sodium 
sulphate (Na2S04). The solvent was then removed in a rotary evaporator. The 
remaining residue was kept at -80°C until analysis.
23 R5 medium: Sucrose 103 g/1, K2S 04 0.25 g/1, MgCl2-6H20  10.12 g/1, Glucose 10 g/1, 
Casaminoacids 0.1 g/1, Yeast Extract 5g/1, TES buffer 5.73 g/1, 2 ml Trace Element Solution (ZnCl2 40 
mg/1, FeCl3-6H20  200 mg/1, CuC12-2H20  10 mg/1, MnCl2-4H20  10 mg/1, Na2B4O7 10H2O 10 mg/1, 
(NH4)eMo70 24-4 H20  10 mg/1. At time of use the following solutions were added per 100 ml of 
medium: 1 ml 0.5% KH2PQ4, 0.4 ml 5M CaCl2-2H20 , 1.5 ml 20% L-Proline, 0.7 ml INNaOH.
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The samples were sent for analysis using Mass Spectrometry by the 
Department of Biochemistry of Vanderbilt University School of Medicine, Nashville, 
Tenessee.
2.9.2 Mass Spectrometry
Mass spectrometry was applied in the search of flaviolin in extracts of S. 
coelicolor cultures in YEME medium. To this purpose HPLC/MS analyses with 
electrospray ionization (ESI) were performed.
The compounds in the sample were therefore first separated by Reverse Phase 
HPLC according to their retention time in the column which depends on the polarity 
or hydrophobicity of the compounds. The more hydrophobe is a compound the 
longer is going to retain inside the column.
The mass spectra were obtained with a Finnigan TSQ Quantum mass 
spectrometer in the positive ionisation mode with electrospray voltage 4.0 kV and 
300° of capillary temperature. HPLC separations were made with a YDC ODS-AQ
2.0 mm x 250 mm reversed-phase octadecylsilane column with a linear solvent 
gradient from 90% of 0.5% v/v formic acid/0.01% v/v trifluoroacetic acid in water 
(solvent A) to 100% of 0.5% v/v formic acid/0.01% v/v trifluoroacetic acid in 
acetonitrile (solvent B) over 20 min, followed by isocratic elution with solvent B for 
10 min at a flow rate of 200 pl/min.
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3 RESULTS
3.1 REDIRECT
In order to delete the gene encoding CYP158A1 in the parental strain of S. 
coelicolor, to obtain a single mutant, and in a CYP158A2 gene deletion mutant, to 
obtain a double mutant for both genes, a PCR-based methodology was undertaken. 
CYP158A2 gene was previously replaced in our laboratory using a construction 
carrying an apramycin resistance gene. CYP158A1 gene (sco6998) was replaced 
within the cosmid 8F11 with a construction which carries a 
spectinomycin/streptomycin resistance gene as a selective marker (spectinomycin 
cassette). The introduction of the mutation into S. coelicolor was achieved by 
conjugation with an E. coli strain carrying the disrupted cosmid. This cosmid 
contains ampicillin and kanamycin resistance gene as additional selective markers. A 
single cross-over between the disrupted cosmid and the chromosome of S. coelicolor 
leads to the insertion of the whole cosmid inside the chromosome providing 
ampicillin/kanamycin and spectinomycin resistance to the exconjugants. The gene 
replacement event only occurs when a double cross-over takes place during 
recombination, providing exclusively spectinomycin resistance.
3.1.1 Screening for double-cross over exconjugants
Ampicillin was the antibiotic used to screen the exconjugants for the correct 
antibiotic resistance phenotype. The parental strain of S. coelicolor was tested for 
growth in different ampicillin concentrations in MS medium. No growth was 
detected at an ampicillin concentration of 250 pg/ml, therefore this was the 
concentration used for the screening of double cross-over exconjugants.
104 of the exconjugant colonies for the screens for the single sco6998 
(CYP158A1) deletion and 116 for the double CYP158A1 and CYP158A2 gene 
deletion that grew in the MS plates with nalidixic acid and spectinomycin were 
plated in replica-plates with spectinomycin (100 pg/ml) with and without ampicillin 
(250 pg/ml). 18 out of the 104 exconjugants for the single disruption and 15 out of 
the 116 exconjugants obtained for the double disruption did grow in plates with
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spectinomycin and did not grow in plates with spectinomycin and ampicillin. A 
single colony from each clone was obtained by streaking and they were replica- 
plated again to confirm ampicillin sensitivity.
12 exconjugants for the single disruption and 14 for the double were finally 
confirmed to be spectinomycin resistant and ampicillin sensitive, thus suggesting that 
the double cross-over took place and the replacement of the gene was successful. 
Those exconjugants were furthered analysed by different means to confirm the 
deletion.
3.1.2 Confirmation by Southern Blot
A DNA fragment containing the gene sco6998 (CYP158A1) and another one 
containing the spectinomycin cassette used as probes were set to hybridise with 
genomic DNA from the mutants by Southern Blot Hybridisation. The detection of 
signal for the cassette probe and the absence of signal for the gene probe in those 
mutants would confirm the gene replacement.
Four samples were initially selected to analyse by Southern Blot 
Hybridisation. Samples named 3, 10, 13 and 21 were the ones chosen.
The Southern Blot analysis was unsuccessful. It was not possible to obtain 
enough signal for the wild type sample, therefore the results are inconclusive.
DNA concentration and quality of the wild type strain, of the mutants and the 
probes were measured with a nanodrop spectrophotometer at 230 nm of wavelength. 
The purity of the sample with respect to protein contamination was measured as the 
ratio 260/280. Proteins tend to absorb at 280 nm and DNA at 260. A 260/280 ratio of
1.8 is generally accepted as pure DNA. The results are shown in figure 16 and 17.
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F i g u r e  1 6 .  Spectra obtained with Nanodrop Data-viewer. DNA concentration (shown in the green 
squares in ng/pl) of the parental strain and the mutants. The purity of DNA is shown in the red square
as the ratio 260/280.
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"8^ - 185.9 135.9
a) 168A1 gene (Probe DNA) b) Spectinomycin Cassette (Probe DNA)
F i g u r e  17. Spectra obtained with Nanodrop Data-viewer. DNA concentration and purity of the 
probes, a) 158A1 gene probe, b) Spectinomycin cassette probe. DNA concentration is shown in the 
green squares in ng/pl. The purity of DNA is shown in the red square as the ratio 260/280.
3.1.3 Verification by PCR
PCR reactions were done for each clone with the correct phenotype. The 
expected size of amplified fragments with each set of primers in the parental strain 
and in the mutants with the gene sco6998 replaced by the construction is shown in 
table 1. Primers 158AlconFl and 158AlconRl amplify a DNA fragment of 1650 bp 
in the wild type, containing the gene sco6998 (1223 bp). If the deletion is successful, 
these primers will amplify a fragment of 1851 bp, corresponding with the insertion of 
the spectinomycin cassette, which is 1424 bp long, 201 bp longer than sco6998. (See 
figure 15 for more detailed size fragments).
The sequences of the primers used in each PCR reaction are shown in annexe 
2. Figures 18 to 20 show the bands obtained for each PCR amplification.
Set of primers
Expected size of amplified fragment (bp)
Parental Strain Gene Replacement
158A lcon F l
158A lcon R l
1650 1851
SpmCssF
SpmCssR
- 1327
SpecIntF
158A lcon R l
- 826
T a b l e  1 :  Size of amplified DNA fragments with each set of primers
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One band of approximately 1800 bp was detected for samples 10 (putative 
single mutant for CYP158A1 gene) and 13 (putative double mutant for both 
CYP158A1 and CYP158A2 genes) when amplifying the DNA with flanking primers 
for the gene sco6998 encoding for CYP158A1, which corresponds with the 
amplification of the spectinomycin cassette inserted in the place of the gene (figure 
18). Samples 1, 4, 5, 6, 7, 11 (putative single mutants for sco6998) and 20 (putative 
double mutant for CYP158A1 and CYP158A2 gene) showed a band of 1600 bp, the 
same size as the fragment obtained for the parental strain using the same pnmers. 
Two bands (of approximately 1600 and 1800 bp) were obtained for samples 2, 3, 8, 
9, 12 (putative single mutants) and 14 to 19 (putative double mutants). Samples 21, 
22 and 24 did not show any band.
Wt 13 14 15 16 17 18 19 20 21 22 23 24 25 26
—  -  *-» m  - 1  t s  w  —
F i g u r e  1 8 .  0.8% agarose gels showing the PCR amplification of genomic DNA from the 
putative mutants using the primers 158AlconFl and 158AlconRl (flanking primers for the gene 
sco6998 (CYP158A1)). First and last lane in each gel: 1 kb marker. Second lane, wild type DNA. The 
gel on the left is showing DNA from putative single mutants for the gene sco6998 encoding for 
CYP158A1 (samples 1 to 12). The one on the right is showing DNA from putative double mutants 
(with gene for CYP158A2 previously deleted) (samples 13 to 26). The band in the “wt” lane is 
approximately 1600 bp. The second band in some of the lanes is approximately 1800 bp.
A band of approximately 1400 bp was obtained for samples 1, 2, 3, 8, 9, 10, 
12 (putative single mutants for CYP158A1 genes) and 13, 14, 16, 18 to 21 (putative 
double mutants for CYP158A1 and CYP158A2 genes) when amplifying the DNA 
with the flanking pnmers for the cassette (1327 bp long) (figure 19).
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F i g u r e  1 9 .  0.8% agarose gels showing the PCR amplification of genomic DNA from the putative 
mutants using primers SpmCssF and SpmCssR, annealing at both ends of the spectinomycin cassette. 
First and last lane: 1 kb marker. Second lane: Spectinomycin cassette as probe. Third lane: wild type 
DNA. The gel on the left is showing DNA from putative single mutants for the gene sco6998 
encoding for CYP158A1 (samples 1 to 12). The one on the right is showing DNA from putative 
double mutants (with gene for CYP158A2 previously deleted) (samples 13 to 26). The size of the
bands are 1400 bp approximately.
There was no amplification product detected for samples 4 to 7 of the 
putative single mutants for CYP158A1 gene, and 24 to 26 of the putative double 
mutants for CYP158A1 and CYP158A2 genes when amplifying DNA with a primer 
annealing inside the cassette, like for the parental strain. The rest of samples showed 
an amplification product of approximately 800 bp (figure 20).
F i g u r e  2 0 .  0.8% agarose gels showing the PCR amplification of genomic DNA from the putative 
mutants using primers SpecIntF (annealing inside the spectinomycin cassette) and 158AlconRl 
(reverse flanking primer for the gene sco6998). First and last lane: 1 kb marker. Second lane: wild 
type DNA. The gel on the left is showing DNA from putative single mutants for the gene sco6998 
encoding for CYP158A1 (samples 1 to 12). The one on the right is showing DNA from putative 
double mutants (with gene for C YP158A2 already deleted) (samples 13 to 26). The size of the bands
is approximately 800 bp.
3.1.4 Confirmation by Sequencing
In addition to PCR screening we performed DNA sequencing of the 
diagnostic fragments in order to confirm the gene deletion event. Primers flanking
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the locus of the gene sco6998 at both ends were used for sequencing in order to 
detect the insertion of the cassette in the chromosome by companng the sequence of 
the junction with the sequence of the parental strain.
PCR reactions (figure 21) were earned out with samples 3,10 (putative single 
mutants), 13 and 21 (putative double mutants) in order to amplify a DNA fragment 
corresponding to the sco6998 locus (with primers 158AlconFl and 158AlconRl, 
see annexe 2.) and another fragment containing only part of the spectinomycin 
cassette (pnmers SpecIntF annealing inside the spectinomycin resistance gene and 
158AlconRl).
F i g u r e  2 1 .  a )  PCR with flanking primers 158AlconFl and 158AlconRl for the gene sco6998.
Samples 3 and 10: putative single mutants. Samples 13 and 21: putative double mutants. The bands 
obtained are approximately 1600 bp for the wild type and the smaller band of the sample 3 and 
approximately 1 800 bp for the rest of the bands, b )  PCR with SpecIntF, annealing inside the 
spectinomycin cassette, and 158AlconRl. The bands obtained are approximately 800 bp.
All the bands that appeared after running the samples in agarose gels were 
extracted and sent for sequencing using appropriate pnmers. The sequence obtained 
for every sample was aligned and compared with the sequence of the chromosomal 
DNA contained in the cosmid 8F11 and the sequence of the spectinomycin cassette 
contained in the plasmid pIJ778 (both sequences were found in the GenBank* 
database). All the alignments were carried out with the pair-wise alignment tool 
available in the software Vector NTI 9.0 (Informax).
Pnmers 158AlconFl and 158AlconRl (annealing 225 and 202 bp 
respectively from each end of the gene sco6998, figure 22) were used for sequencing 
of both sides of the gene sco6998 locus in order to try to confirm the replacement of
53
the gene by the spectinomycin cassette. The position and orientation of the gene 
within the chromosome is shown in figure 23. Within the cosmid, the gene sco6998 
is located between bases 25688 and 26911.
R everse primer
sco6998  (1 2 2 3  b p )
Forward primer
F i g u r e  2 2 .  Position of the sco6998 flanking primers 158AlconFl (forward) and 158AlconRl
(reverse).
SC06998 SC06999
7,768.000 7,770,000
-
S C 0 7 0 0 0
! 1 1 ' ' I ' ' ' 1 i
7,772.000
F i g u r e  2 3 .  Position of the gene sco6998 with respect to the chromosome. Image extracted from 
ScoCyc (http://scocvc.streptomvces.org.uk: 14980/SCQ/NEW-IMAGE?tvpe=FULL-
MAP&obiect=SCQ6998)
SpecIntF (a primer annealing inside the spectinomycin resistance gene, see 
figure 24) was also used to sequence as an additional proof of the insertion of the 
spectinomycin cassette.
1292593 bp 819 bp
CD
p l J 7 7 8
699 2110Internal
Primer
F i g u r e  2 4 .  Position of the internal primer (SpecIntF) used for sequencing and the spectinomycin 
cassette with respect to the plasmid pIJ778. The location in the plasmid is indicated in blue. 
Spectinomycin cassette is located between positions 699 and 2110 within the plasmid. The internal 
primer anneals in position 1292 of the plasmid, 593 bp away from one of its ends.
The DNA sequence obtained from the parental strain DNA (figure 25), used 
as a control, coincides almost completely with the cosmid 8F11 sequence in both
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sides of the sco6998 locus. There is no coincidence with the plasmid pIJ778 
sequence in either side.
(19079) 19079 .19090 .19100 .19110 19120  ,19130 7.9140 .19150 .19160 1 9 170  .19180 19190  3.9200 .19210 19223
(19079)03 AC TPC 
• J  (1) —  GG ATA
(19224) 1 9 j2 4 .1 2 .2 3 J ____ ,1 9 j ± 2 ____ ,m S S ____ 1 2 2 ^ 0 ____ .1 9 2 7 0____ ,1 9 2 8 0 ____ 1 9 j 9 0 ____ 19 3 0 .0 ____ 1 9 3 1 0____ . I j j j g ____ .12.330____ 1 9 3 ^ 0 ____ .1 9 3 5 ? _______1 9 3 5 8 .
(19224)
I >44)
(19369) 1 2 2 5 2 _____ 1 2 1 2 2 ____ 1 2 2 2 2 ____ 1 2 1 2 2 ____ 1 2 1 1 2 ____ 1 2 1 2 2 ____ 1 2 1 2 2 ____ 1 2 1 1 2 ____ 1 2 1 2 2 ____ 1 2 1 2 2 ____ 1 2 1 2 2 ____ 1 2 1 2 2 ____ 1 2 1 2 2 ____ 1 2 5 2 2 ,1 2 5 1 2 .
(19369) <■ , !•  i -  ,1 \ .V i 7 AA - • A ■ W  V,i T! . . 7- ,V ,:• ,v ,  - n  ,7 , . a t  a  !T -T .:
(289)
(19514) 1 3 2 1 4 1 2 5 2 0 _____ 1 3 5 1 0 ___1 2 5 1 2 ____ 1 2 5 5 0 ______ 1 2 5 5 2 ___ 1 2 5 2 2 ___ 1 2 5 5 2 ______ 1 2 5 2 2 ____1 2 5 2 2 _____1 2 5 1 2 ____ 1 2 5 2 2 _____1 2 5 1 2 ----- 1 2 5 1 2 ------------1 2 5 5 5 .
(19514)........................................................................................................................................................................................................................................................................................... ................
(4341 o a  A T r .?)A .> :> :>> :i9T T ro3C T 03C P 3rC T iciaa»aa3«ixaaia3a«cm T g a a m r a ^
(19659) 1 2 5 5 2 ____ 1 2 5 1 2 ______1 2 5 2 2 _____1 2 5 2 2 ___ 12 .7 0 2 _____ 1 2 2 1 2 ____1 2 2 1 2 _____1 2 2 1 2 ____ 1 2 2 1 2 ___ 1 2 2 5 2 ____ 1 2 2 5 2 _____ 1 2 2 2 2 _____1 2 2 2 2 ____,1 2 7 2 0  1 2 8 0 2
(196591 . . . . .
i m ) T 9 9 c » s w ( r ! 0 3 c a » t t m ] ic m 3 3 m * 3 3 < n c i3 r a 3 a 7 n ? r a ! f r x i r r r c p ? 3 a 'C G r a ! m ^
(19804) 1 3 8 0 4 1 2 8 1 0 _____ 1 2 2 1 2 ___1 2 .8 1 2 ____ 1 2 8 1 2 ______1 2 2 5 2 ___ 1 2 2 5 2 ___ 1 2 2  70______ 1 2 2 2 2 ____1 9 8 9 0 _____J 2 2 2 2 ____ 1 2 2 1 2 ____ 1 2 2 2 2 ___ 1 2 2 2 0 _______ 1 2 2 1 2 .
(724)
(19949) 1 3 3 4 2 _____1 2 2 5 0 ______.1 3 2 7 0 _____,1 9 3 8 0 ___ .1 3 3 9 0 _____ 1 2 0 2 2 ____1 2 2 1 2 _____1 2 2 1 2 ____ 1 2 2 2 2 ___ 1 2 2 1 2 ____ 1 2 2 5 2 _____ 1 2 2 5 2 _____1 2 2 2 2 ___ 2Q08Q 2QQ32
119949) c
(869) . G G T
(20094 ) 20  Q 34101Q 0_____ 1 2 1 1 0 ___1 2 1 1 0 ____ 1 2 1 2 2 ______1 2 1 1 0 ___ 1 2 1 5 2 ___ 1 2 1 5 2 ______ 2 0 1 7 0 ____ 2 0 1 8 0 _____2 0 1 9 0 ____ 2 0 2 0 0 _____2 0 2 1 0 ___ 1 2 1 1 0 _______2 2 2 2 2 .
(20092) cA C GAG G G CGTG - C  C C C G A
(1014) GC T A— -  G TCT G T - — -  G
(20239) 2 0 2 3 3 _____ 1 2 1 5 2 ____ 2  0 2 60___ 2 0 2 7 2 ____ 2 0 2 8 0 ____ 2Q29Q____ 1 2 2 2 2 ____ .2 0310____ 2 0 3 2 0 ____ 2 0 3 3 0 ____ .2 0 3 4 0 ____ 2 0 3 S 0 ____ 2 0 3 6 0 ____ 2 0 3 7 0  2 0 3 8 3
C 7\/0330ZAX^J11L'1'GC30333033I)3T\
1 . 3) Wild Type_F/8F11
(1693) 1693 27 00  1 7 1 0  .1720 1 7 3 0  1 7 4 0  .1750 .1760 .1770
(1693 )pc  ' TCATT G3 T  A1TITIU1' A T  T A G  G C  A C C T T G  — A A G  O T A  G G  C T IT  TA Q3IT T  ULTH'IU TITIUL’IL' A  TT TTT T  C A0C
(133)—  0 3 3 0 2  CKC IE  0 3  G G O ®  T  G G A0GC C O J G C  A  C37T A  C G CAG 03 CMX C TO33OT 03 03 7 1 0 3 .0  GA 1337 G A  O T
(1985) 1985.1990
(2131) 2131 2 1 40
.24111 24 2 2
(2423) 2423 2 4 3 0
(2418) • GC TA TTC. TAT CT
(773) AT AC GAG GTG 07
2 5 1 0 ______1 5 1 2 .
(27151 2715 3720
(2861) 2861 3870
(2853)C A  —  03ITG T  G C T  . ATTT T G3C C - . G GGA
(1156) A G TC A O T T - A T A ----G------- A CCA T ACT  TAG
1 b ) Wild Type_F/plJ778
F i g u r e  2 5 . 1  Control DNA (Wild type) sequence from the right side of the sco6998 locus (using 
primer 158AlconFl) aligned with the cosmid 8F11 (a) and the spectinomycin cassette (b) sequence. 
The coinciding bases are shown in red.
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(25488) ^ 5 4 8 8 _______2 5 5 0 0 ____ 2 5 5 1 0 ____2  5 520___2 5 5 8 0 ______2 5 5 4 0 ____ 2 5 5 5 0 ___2 5 5 6 0 ___ 2 3 5 7 0 ____ 2 5 5 8 0 _____2 5 5 6 0 ____ 2  5 6 0 0 ___ 2 5 6 1 0 ____2 5 6 2 ( 2 5 6 3 2
F1154 8 8 0T G C G  C G «  -
<J» (1) — C A A G CIG A
(25633) 2 5 6 3 3 .2 5 6 ,4 0 ____ 2 5 6 5 0 ____ 2 5 6 6 0 ____ 2 6 6 1 0 ____ 2 6 6 6 0 ____ 2 6 6 2 0 ____ 2 6 7 0 0 ____ 2 6 1 1 0 ____ 2 6 2 2 0 ____ 2 5 2 3 0 ____ 2 5 .7 4 0____ 2 6 1 6 0 ____ 2 6 1 6 0 _____ 2 5 2 2 2 ,.
(25632)
(144)
(25778) 2 5 I2 A ______ 2 6 ,7 3 0 ____ 2 6 6 0 0 ------2 6 6 1 0 ___2 6 6 2 0 ______2 6 6 3 0 -------2 6 6 4 0 ___2 6 6 6 0 ____2 6 6 6 0 ____ 2 5 3 7 0 _____2 6 6 6 0 ____ 2 5 8 3 0 ___ 2 6 6 0 0 ____2 5 3 1 1 2 5 3 2 2 .
125777)
(289) 07>.7 7W J.^.T'J5*93A?M T'JIvm X»(A!CTOM rPi3a'337CO33A)Jl'i5M 47i7,T4'AiAA';i..>7r C . . . . iTW A J3Tl>3j l l ' fa 3 C73G ro3Q 3ta5AJ)M 37ro)3aj703Q33(A
(25923) 2 5 3 2  3 2  5 3 3 0 _____ 2 6 6 4 0 ____2 5 3 5 0 ____ 2 6 6 6 0 ____ 2 6 6 2 0 ___ 2 6 6 6 0 ___ 2 6 6 6 0 ____ 2 6 0 0 0 ____2 6 0 1 0 _____2 6 0 2 0 ____ 2 6 0 3 0 ____ 2 6 0 1 0 ____2 6 0 5 0 _____ 2 6 0 6 2 .
(25922) 707D V 33A 3A :rjrA ^5B ?J])^035D 39a*Ivi m JTrXD7IG3V’ rrCliA'.tiTXr73V3CUa»T7>03:073A5>aiA:'‘.l3A?71'r'.77I>i)a«A,I'(J30JjO U »3?ro:.
(434)
(26068) 2 6 0 6 8 ______ 2 6 0 8 0 ____ 2 6 0 3 0 ____2 6 1 0 0 ___2 6 1 1 0 ______2 6 1 2 0 ____ 2 6 1 3 0 ___2 6 1 4 0 ____2 6 1 6 0 ____ 2 6 1 6 0 _____2 6 1 2 0 ____ 2 6 1 8 0 ___ 2 6 1 6 0 ____2 6 2 0 1 2 6 2 1 2 -
(26067)
(579) TO 3w3XDm ra>a3caxo3993.7T7r]X73:i3C 3w :n>M T3a':2w :Toy»>T..i7r.jA .):A tf:^
126213) 2 6 2 1 3  2  622Q _____ 2 6 2 3 0 ____2 6 2 4 0 ____ 2 6 2 6 0 ____ 2 6 2 6 0 ___ 2 6 2 2 0 ___ 6 6 2 8 0 ____ 2 6 2 9 0 ____2 6 3 0 0 _____ 2 6 3 1 0 ____ 2 6 3 2 0 ____ 2 6 3 3 0 ____2 6 3 4 0 _____ 2 6 3 5 7
(26212) ■ TO IIlto3ay3h3rA3ajlxm m 3rro5C!m B3O X G Q 33305O ia3G TCTO 33IQ m 33(O D 33BC Am D D D3nTa33IO 3733033K X JCr3
(724) <357rcK73CCGhXTOOin3CO3OOTCG03G3I*XGMCTMGflGrA3lCOTO3COI1^7rc*?r!'3Oro3CDOO339(7!13,3(4AJICrO97PjA,!'414t7.73jPACA1>t737.\7nT.73.' 0 0 0 3 8 0 3 3  CUCBSCN1330
(26358 ) 2 6 2 6 8 ______ 2 6 6 2 0 ____ 2 6 6 8 0 ____2 6 6 6 0 ___2 6 4 0 0 ______2 6 4 1 0 ____ 2 6 4 2 0 ___2 6 4 6 0 ____2 6 4  40____ 2 6 1 5 0 _____2 6 4 6 0 ____ 2 6 4 7 0 ___ 2 6 4 3 0 ____2 6 4 3 1 2 6 5 Q 2
(26357) «T O 30C aC n X C S SK D  O CTGKGKGSOSKII A  -
(889) AlAl?TiTiA3ATi5ATrr>XX7.1jTO^)3A7T'.l^^:rCT'TO30T'3X739STO7^TO.11F.T.^Il7rix>'l',Viijoj5-j^3lT3XlGAMja.TO^.9»X^'.T'.t'1A T A '-7 r'. . .  11 :■ . c
(26503) 265Q 3  2 6 5 1 Q _____ 2 6 5 2 0 ____2 6 5 6 0 ____ 2 6 6 4 0 ____ 2 6 5 5 0 ___ 2 6 5 6 0 ___ 2 6 5 2 0 ____ 2 6 5 8 0 ____2 6 5 6 0 _____ 2 6 6 0 0 ____ 2 6 6 1 0 ____ 2 6 6 2 0 ____2 6 6 6 0 _____ 2 6 6 4 7 -
(26499) C • C G K » G K 7 G T G  G G G GA G A G G 0 3
(1014) C - A AG-- C GT A -  -  A A C O S  -  -  T C —
2 6 6 6 0 ____ 2 6 6 2 0 ____ 2 6 6 8 0 ____ 2 6 6 6 0 ____ 2 6 2 0 0 ____ 2 6 2 1 0 ____ 2 6 2 2 0 ____ 2 6 7 3 0 ____ 2 6 7 4 0 ____ 2 6 7 5 0 ____ 2 6 7 6 0 ____ 2 6 7 7 0 ____ 2 6 7 8 1 2 6 7 3 2
2 .  a )  Wild Type_R/8F11
(293) 223____6 0 8 -
520_______ £30_______£40_______ £50_______ 560
(578) C GGITTT A T  C A  T  GT AA CGPC G CM7T AIT T ATA ACICA TATA ATTG TA
(277) G CCDCAG C G  , - C  C  C D 03 G3JT T  , <XA C OCT GTCTG ATCC GCAC CG
(724) CT A T T  TA AGAATAflAACT AAT GA T AT AG T A CCAATC A T CGA C G A CT TTT CG TA CTT T CTC CIT A AGIGGA A AT T
(412) G- G QG CG G--------------------- GGA G C D O TG G  TTG3CG C A  TAC A A  G AC CEG TC — G3C C------------- GCG C GCACCT G CG C
(877) 877
(870),,
(1023) 1023 .1030
(1161)M  T T T  TT CTT TCT A T A  G  TH3 A A O A  T S f f G T  T G  AAGKT TC A  ATCIt: T- CG
(803)G - ~ C G  1 G - TCA d A  CCGT C f f lC  C - T — ^ G C O S T C  G C '  OO  ( E G ,  .0 3 1 0 9 3 1  AT
(1315) 1313 4320
(1305 )G TC TGAC A A T  T CT TAOCC C OWA TCT G T  ’ TC AG GAA AA TT AAAAG T  TT AAAGT GC C  TTGT T  TC AG ' TAD GT ACC T AC
(939 )C C T  G C C ,  — GGGAG G CTCE GGA C G ' GA CA TOS —  GG OXTC G AG CC--G CA A ACCG C GG T - OCT CG CGG G CG
(1461) 1461
(1451) A T TGIG CIT A  G 
(1072) G C A C G A A C G -C
2. b) Wild Type_R/plJ778
Figure 25.2 Control DNA (Wild type) sequence from the left side of the sco6998 locus (using primer 
158AlconRl) aligned with the cosmid 8F11 (a) and the spectinomycin cassette (b) sequence. The 
coinciding bases are shown in red.
Two bands were obtained for sample 3 (putative single mutant) when 
amplifying the fragment corresponding to the sco6998 locus. The DNA sequence 
obtained for the largest band (figure 26) coincides with the parental chromosomal 
sequence only in the regions flanking the sco6998 reading frame. The DNA sequence 
which would correspond to the sco6998 internal coding sequence in this sample 
shows coincidence with the sequence of the spectinomycin cassette.
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(19075) 1 7 0 7 3 9 0 8 0  1 9 090  19100  19110  19120  19170  .19140 19150
•F11 (1907503 A C A31T C
158A1_S_F_» ( 1 ) - -  -  T ---------
(19218) 1721*
(19218) 0 3  A  A f C  AC ACG -  1X3333 03  C 0 3  C G3I33G G CT 0 3  33 CIC FC TC A  -  G T I C A C D G C T  OC
(136) *. i ■    T T C  <3 T O T S C  G OTTOS! • TC T TT T TW»AA T TA AA TT AAA IT  OC C  T C .  G AG A  T  C TT
(193611 19361 .19370 .19380 .19390 .19900 .19910 ,19920 ,19430 .19990 .19450 ,19960 .19470 .19480 ,19490 19503
(19359) TCATO 
(276) AC  . O T ® A  333A
1 • a ) 158A1 3 F S/8F11
plJ778 (2067)03 A  T TAC TTTAT TTC CT TAT TTGT T AAT GAG A AA AATT A  A3AG AAA AGO AT , CAT AT A  CCAA CG A  TT A  CCT AC AAA GAA AAA
158A1 3 F sO ) — G • A  C IG . 33—A  33G TC G03 3333 G —C 0 3 -  • C  03 0333 G TG3C 333 103 C - . 333 TG C --------------GA G 3 3 C  333 3 3  0 3 -  • TO3 03 3  .
2250 2260 2270 2280 .2290 (2300 .2310 ,2320
(2208) T CA G T G G  CT UV AA TA TC 1C03333 C CA A  TOG AT C G A
(129) A  TC C - A A  GG 33  TG 33 0 3 ------------------ G: GG G  G—  —  -  A G
(2349) A A
(257) G G
2^400
158A1__3_F_s/pU778
(25480)25480 25490 25500 ^5510 25520 ^5530 ^5540 ,25550 25 25610 25624
8F11 (25480 ETCCT CX3C GOT* CC -  G GAT 
168A 1_3_R(1>-*A«5 ATA TTA TA T T CEA
(25625)2562^5630 ,25640 ^5650 ^5660 ^5670 ?5680 ?5690 ,25700 ^5710 p5720 25730 ,25740 j25750________25769
(25624) CT COG TCCA G A G GOXDG^ CCT A A GOT G G333X G3CC C G TCG3X G OTGA3
(144) TC TGTA GTTG A  T T  AAA T  C ATA T TAGKiA TA33 A T GGAATA A TTATCA
(25770)25770 25780 25790 25800 25810 25820 25830 25840 25850 .25860 25870 25880 25890 25900 25914
2. a) 158A1 3 R S/8F11
>00 £10 ,520 >30 >40 >50_______£60_______£25_______£80_______>90
pU778 (4 58)TCEC C T GXA TCA G CAACT TGG A3 GAT TGCG <33 T  T  GCTA T CCA T G  A G  * GAT G TG AA
160A1 3 R  (D - -A A G  A TTAC ACT C AO®G GCT <X 033---- -------AG A  G C03C G  —  C A  C  T • 005 '  T  AC
(604) 604 610_______ 620_______ 630_______ 640_______ 650_______ 660_______ 670_______ 680_______690_______ 70
.830
2- b)
|7‘ 9) . . C G C  A -  C G  G CT
(261) ■ -  C T T T A T  T  A -
158A1_3_R_s/pl J778
Figure 26. DNA sequence obtained from the largest band in sample 3 (see figure 21. a) (putative 
single mutant for CYP158A1 gene), from the nght side (using forward primer 158AlconFl) (1) and 
from the left side of the gene (using reverse primer 158AlconRl) (2), aligned with the chromosomal 
DNA sequence contained in the cosmid 8F11 sequence (a) and with the spectinomycin cassette 
sequence contained in plasmid pIJ778(b). The coinciding bases are shown in red.
The DNA sequence obtained from the smallest band for sample 3 (figure 27) 
shows only coincidence with the chromosomal sequence and not with the 
spectinomycin cassette.
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(19081) 190 81 ,19090 .19100 .191 10 ,19120 .19130 .19140 .19150 1 9 170  .19180  19190  .19200 .1921019221
8F11 (19081)GA. C -  CA C
158A1_3_F_I (1) — G C
(19222) 19222 ,192 30 .19240 .19250 ,19260 .19270 ,19280 .19290 .19300 ,19310 .19320 ,19330 .19340 .19350 19362
(19221) 0 3 A  A C  fiCfiCG -  0X 3332  C G C C C C O T C G  C C GT G C  G C • C G
(139) TTC  G T G T ® C  G GTTOGA T C T T T T T A - M  A G C T  A T  C A  G A
(19363) 19363 .19370 .19380 .19390 .19400 .19410 .19420 .19430 .19440 .19450 JL9460 ,19470 .19480 .19490 19503
(19361) C A  - C CC . . . . . .  A -  G
(279) G G A  TT C T
(19504) 19504.19310 ,19520 1953
(19502) G <
(420) C CT
.195 5 ,19570 ,19580 .19590 .19630
1 . a ) 158A1 3 F i/8F11
2100 .2110 a  120 ,2130 ,2140 ,2150 ,2160 ,2170 .2180 >>190 2 2 0 0
p(J778 (2077)TA T T  G 'T C  CT W I T  GT AATT TOA C C3VTAA AWT A A A  AAA A  CIAT PC AT ATT AA CT A— TT — ^  CT ACYAAA GVX AAA T CA
158A1_3_F_I ( 1 ) —  G C  -  GA PG 0 3 2  —  CC1 0333  CDS G CTOTO 0337 G -  G • TOG T  GDG- 0 3  TC TOG O T IC  CTOGGOG GG CGGTCD TOC CCE A TC
(2219)2219 
(2215)
p230 .2240 ^25 0 £270 £28 0 ,2290 £3 00 2310 .2320 £330
GT G  G • CT TA  AA m  TG TOCXTD3 C  CA A  TOG AT C - A T  A  AA T (5\ G T CD C A  TOG A  CPG
(136) C - A A  GG GG TO GC GC ------------  G GG G G— —  -  G A  G • CD ' C TO A  -  TO A  C •  G TTA
(2361) 2361 2370 2380
(2357) TT C T  GPG A  GC- A  G 
(261) A — G G'OCT G AA3 T  A
2400 .2410 2420 2440 2450 ,2460 £470 2490 2502
APflAA A  AG
G333- C GC
PGAPG APCA C • G <33T GC T CTT PC C W  C C T
0333C T  G 1 C ‘ CPC —  G G3S TOGS—  G T -  -
C T O  T- PCC 
G PC CG GTO
AA GTOT C A ----- T
CG TCPC A  T 033 C I
(2503) 2503 2510 2520 2530 2550 £560 £570 2590 £600 2630
(2494) AAAA CCT T O  TCGTO AA A  GG T GA A A GAAAA ArC3CIATAATT?OXa3VraA33^ TO UCPQ33?PAAT3CPQCK7m 3I7VOGAT3X^
(392) 0333 TGA GTO CQCCA TO T-TC C 0 3  C  C COCCT -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
1 . b ) 158A1_3_F_i/pU778
(25481) 25481 2 5 4 9 0  2 5 5 0 0  25 51 0  2 5 5 2 0  25 5 3 0  2 5 5 4 0  25 5 5 0  2 5 5 6 0  25 5 7 0  2 5 5 8 0  2 5 5 9 0  2 5 60 0  25 6 1 0  25623
0F1425481 )t o c  a X E  Q 3 3 X 0 3 . C G A T  . ................
158A1_3_R_I (11 —A O JIA  TOCIGKT A C TO
(25624)  I S W ____ a m ____ z s m ____ __________ .25680____ 2 5 6 9 0____ 2 5 7 0 0 ____ 2 5 7 1 0____ 25 72 0____ 25 7 3 0 ____ 25 7 4 0 ____ 25 7 5 0 _____25760
(25624) CT CCfiG T  CA A G G GC G C CA C A
(142) TC TGTAGTG T T C A A T  A  TT A T
 a m  ____ 2 5 8 1 0____ __________ 2 5 8 3 0____2 5 8 4 0  2 5 8 5 0____ 25 8 6 0 ____ 2 5 8 7 0  2 5 8 8 0____ 2 5 8 9 0_______ 25909
2. a)
(25767) 25767(257#7|A77:77.m77TA91CATO*7DXA91A9^.1T7SA3^>^5TO3TO^J7»XW3CBfflrAa3(Xl3X03re3fflAAiiTaiTaClXCrn'XlBrAiJ 
128S) M X jy } ^ a o x o 3 3 H & x tK z a 3 Q & x x jr u r c r fo y a x c tW H C T o x c w B O 3 0 0 C N 3 < K iiX K T O K x y M fG r a 3  aa . —
158A1 3 R I/8F11
2850____ 2860
(2874) 2874 2 8 80
2. b) 158A1_3_R_l/plJ778
Figure 27. DNA sequence obtained from the smallest band in sample 3 (figure 21. a) (putative single 
mutant for CYP158A1 gene), from the right side (using forward primer 158AlconFl) (1) and from 
the left side of the gene (using the reverse primer 158AlconRl) (2), aligned with the chromosomal 
DNA sequence contained in the cosmid 8F11 sequence (a) and with the spectinomycin cassette 
sequence contained in piJ778 (b). The coinciding bases are shown in red.
The DNA sequence obtained from samples 10 (putative single mutant) 
(figure 28), 13 and 21 (putative double mutants) (figures 29 and 30 respectively) 
coincides with the chromosomal sequence only in the region flanking the sco6998 
reading frame. The sequence which would correspond to the sco6998 internal coding 
sequence coincides with the spectinomycin cassette sequence.
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(19079) 19 0 79 .19090 .19100 .19110 ,19120 ,19130 .19140 .19150 .19160 .19170 .19180 .19190 .19200 .19216220
8F11 (19079KEG AOCT CA • C 
168A1_10_F (1) —T GGGC TC
(19221) 19221 .19230 .19240 .19250 19260 .19270 19280 .19290 19300 ,19310 19320 19330 .19340 19350 19362
(19221) CG A A C PC ACGCTC G C CGX O X  GG G G33A G O X  CCCTC C GGACG3X G GAC G T  C T
(140) T T C -G  T GT G  T -  TCCA GTT TA T T A AAA TATAG A T ----------------A  CGG A -  A A
(19363) 19363 .19370 ,19380 .19390 ,19400 .19410 .19420 ,19430 .19440 .19450 .19460 .19470 .19480 .19490 19504
(19363) -  G G  A3 G CG T A X  C C GC O X  C G C G GCT GCTGGTGG A C X  AC A G G G AXXATCA C A  GAT GC TOG GGCD3A TG G A XTCAATCAC
(265) G T  C TT A AC G  G G AA AAG G A T  A A A - AA ACC GCT TG—  GG C T--- T C C -------------T T CTG CG GAT I  TT AT A C --------------------
1 . a ) 158A1__10_F/8F11
(2066) 2066__________2080 2090 2100 2110 2120 2130 2140 2150 2160 2170 2180______2190__________2209
plJ778 ( 2066)ACDC A T TAC TTT AT TTC CT TAT TTGT T AAT GAG A AA AATT A TOG AAA AGC AT CAT AT A CCAA CG A TT A OCT AC A M  GAA AAA T
168A1_10_F (1) —TA G • A  CTG G G -A  GGG TC G X  GGCC G — C  X -  C CG CGGG G T3GC GOG TCG C- . GOC TG C--- --------- GA G CG C GGC (33 CC- T X  COS A
 ^  2 m  2 m   2 m  2 m  2 m  2 m  z m  *>340____
CTTA A A T& TS r-TOOXOG • C CA . A TCG HT ’ C tf) EMiJOSPltiifO CTXA .5ITO VWmCTATIVCT *I*GWiJIKI7V. J m ^ n C G W IT r ro  •
OS 0 3  TG GC GC  ------------ ) G GO G G-- - -  G
(2354) ^ . 54 ^ ^ 0 __________  ^ 3 ^ _____ i i i o _____ __________ 2 m _____ 2 m _____ 2 m _____ 2 m _____ 2 m _____ 2 m _____ 2 m _____ 2 m _______
(2354) C A  C
(263) •AriAlTOXTTI'TA^CrVl 1 G G . ' T'7  GAATAAGGGACAfjI' sAAjAAOjAA ACTU * CT T
1. b )  158A1_10_F/plJ778
(25487) 25487_________25500 25510 23520 25530 25540 25550 25560 25570 25580 25590 2 5 60 0 2 5 6 10 2 5 6 2 02 5 631
BF11 (25487 )CG G C  G C G G T
168A1_10_R (1) — T T  C G T T -
(25632) 23632 ,23640 2^650 2*660 2*67 0  2*660 2*69 0  2*70 0  2*710 2*720 2*730 2*740 2 * 7*0 2*760 25776
(25632) CT COG TGCA G A G  GCGCGGAC OCT A A GCT G GGCGOC GGCC C G TCGGCC G CGOGAGC G
(143) TC TCTA GCTG A T T -----------------AAA T  C ATA T TAGAGA TAGG A  T GGAATA A TTATCAG T
(25777) 25777________ 23790 25800 25810 25820 25830 25840 ,25850 25860 25870 25880 33890 23900 2591025921
(25777 )C— G A C  C T C A G G G G C G A  AG -  G C • CTGC CG G GAG GC CD3G C G  G 03 G CCT (E G A  CA CT  G T  GG3G CGOG G TCG TG G CG G -
(280) AAT A T G  AG G - C T  T A TTC GA T C T  G— - TC C TTT T A   G C  A TC T  AAC ATC G GC AG CAA C A  CTTC TCTT A ATA GC T T A C T
2 .  a )  158A1_10_R/8F11
(466) 466___________ 480________490_______500_______ 510_______ 520_______ 530_______ 540_______ 550_______ 560_______ 570_______580_______ 590 600 611
pU778 (466) IT  GCCA T A CG A CT TGG A3 GAT TGCG GC T T GCTA T OCA T G A G  O T  G TC AA TTAA CTXG T M  A GGIT C AG C A C A C T TAAA A
168A1_10_R <1» ~  CX3TG C C  T A G G - GCT OC X G   A G A G  CG3C G —  C A  C T  O G  T  AC -  ----- Q O C X - X  G TCCG G X  —  CG C  033 C G
(612) 612 620_______ 630_______ 640_______ 650_______ 660_______ 670_______ 680_______ 690_______ 700_______ 710_______ 720_______ 730_______ 740__________ 757
(612) G X  TGAA T A TAC C C A ATA G GA TT G A G G C  C - T A  CGA TA GATAAGCTTGATC G
(128) C GG G TX C G CG- G X  GOG C T G C -C  G TCG GG G G CTG X -A--------------------------------------  A
(758) 758_________ .770_______£80_______790_______ .800 010 .820 .830 .840_______£50_______.860 .870 JB80_______£90______ 903
(757) C • -  ■ ,
(260) A3GAACTT-AP3A3 2IICK3OCAKrbSiCIB9GGN3Q(CCXiNZ3TKrrTQ3n9CX&0CTN3SlGKIO03C^
(904) 904 .910_______£20_______£30_______£40_______ £50_______ 960_______£70_______ £80_______ 990 .1000 .1010 .1020______.1030__________ 1049
(902 ) ' • • • . , . - • . • •
(405) 0CTCTCTAGCICTZAACT/CT3AXGXn3ATAiICT33jCD33'!A30-'l v CT XATP9I T3CABP0I > D l  v3GACA30CTT033Z*> ZJGMTITO XB3TDOXO CT3 < T O ) -A ■ ,
(1050) 1050 .1060 .1070 ,1080 .1090 .1100 .1110 ,1120 .1130 >140 .1150 .1160 .1170 .1180 1195
(1048) A G T G GTTXTXDXGCTGGAOCTAO^AQ3CAACGCTAICTTCTCTTGCnTTGrCAGCAAGAT
(551) C C C A A ------------------------------------------------------------------------------------------------------------
2. b)  158A1_10_R/plJ778
F i g u r e  2 8 .  DNA sequence obtained from sample 10 (figure 21. a) (putative single mutant for 
CYP158A1 gene), from the right side (using forward primer 158AlconFl) (1) and from the left side 
of the gene (using the reverse primer 158AlconRl) (2), aligned with the chromosomal DNA sequence 
contained in the cosmid 8F11 sequence (a) and with the spectinomycin cassette sequence contained in 
piJ778 (b). The coinciding bases are shown in red.
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(19075)1907^19080 19090 19100 19110 19120 19130 19140 19150 19160 19170 19190 19190 19200 19217
8F11 (19075X33 G C CCT PC
158A1/A2_ 13_ R 1) — C T --------
(19218) 19218 ,19230 .19240 ,19250 .19260 .19270 ,19280 ,19290 .19300 ,19310 .19320 .19330 ,19340 .19351)9360
(19218) 03 A  A . C AC AXCIC G C COX O X  GG G G03A G O X  O I X  C  03 0333X33 - GAC G T C
(137) TTC  G T GT G  T -  TCGA GTT TA T T —  A AAA TATAG A TC A------------  033 A -  A
MQ3R1) 19361 .19370 .19380 ,19390 .19400 .19410 39420 .19930 .19440 .19450 .19460 .19470 .19480 .19490 19503
1 . a) 158A1/A2 13 F/8F11
(2068) 2068 .2080 2090 ^100 2110 .2120 ^130 2140 2150 ^160 2170 .2180 2190 .2200 2211
plJ778 (2068)03 A  T  T CACTTT TG TTC CT TAT TT3T T  AAT GAG A AA AATT A PCPi3 AAA A X  AT CAT AT A CCAA ' CG A  TT A  (XT AC AAA GAA AAA T  C
168A1/A2_13_Fli -  C A  A T3ACQG GC GGG TC GCC GGX G --C  X -  C 03 G3GG G T G X  GQ3 TCG C - G X  TG C------------  G AG C G C G G C G 3C C - T X  033 A T
(2356) 2356__________.2370 .2380 2390 ,2900 .2410 .2420 2430 .2440 .2450 .2460 .2470 .2480___________2499
(2356)........................................................................................................................................................................................................................................... , AO>CGAACIXnTG3CAAAAT
(265) - -------------------------------------
- l b )  158A1 /A2_13_F/plJ778
(25484) 25484 25490 25500 25510 25520 25530
8F11 (25484 )TG C G  X  C GGAT
168A1/A2 13 R <1>-~ G A  A T --A
(25629)25629 25640 25650 25660 25670 25680 25690 25700 25710 25720 25730 25740 25750 25760 25773
(25629) - - - CT CCAG TGCA G A  ■ G G03333AC CCT A  AGGT G GGQ3X GGX C G T X G X  G O303AGC G
(142) TC TGTA GCTG A T T  AAA T C ATA T TAGAGA TAGG A  T GGAATA A TTATGA3 T
(25774) 25774 25780 .25790 ^5800 .25810 25820
(25774) tc—  G A  C CT CAG G G G X A  PG -  G C - CTGC OG G GAG X  X X  O  G G GG G CGT CIXTACGX GG G TTGGGGT C T C GT G03G C GG
(279) AAT A T G  AG G - C T  T A T O  GA TAC X T  •  G \ TC C  TTT T A   G CV A TC T  AAC--- -------------------TC: C ----------------- A  C A  — CTTCT TT
(25919) 25919 25930 25940 25950 25960 2*970 25980 25990 26000 26010 ^6020 /!6030 ^6040 ^6050 26063
(25916)G3GG CGTC GG GC G GGOGGC G C —  A GT C C CICA C GC A G G03T -  X A C T  G C A G  GG3G AGX CAC33AC T G G G G  C A 03
(398) C- TAAG CT TA C  A ' T r CG G TG T  T  • G—C G CA C O  ATTG A  Q3G AG A T G C  TTT C  GTTA T------------C • T A C A  G G GA
(26064) 26064 26070 26080 26090 .26100 26110 26120 26130 26140 ^6150 26160 ,26170 ^6180 ^6190_______ 26208
(26058) (XAGCT X  G X  G 0 3 X  C OGGX T • G TC CATC C G33GCJ3 G G CAG- X  CA A TG
(526) - A XTA-Vv ■ A —1A ATTT • T  A— T D X  • C -GT • • - GGX T !' CATAGC T A GTTT TT GC ‘ Cl> AA
(26209) 26209 .26220 26230 26240 ^6250 ^6260 .26270 .26280 26290 .26300 ,26310 26320 2 6
(26202) G GXCTCG3T XCD3AC C ■
(655) I T  CAAG3AAAG ' ATGTTCT TT3
2 .  a) 158A1/A2_13_R/8F11
(473) 9 73 ,480
plJ77*473)TT A T  C CAACTGT X  A G  -  T TG G OCTCTT CTATTAC C  A  T G  A G  GAT G TG AA TTAA T T X  TAA A GGTT C AG CAC AC T  TAAA A G X
158A1/A2 13 R |1) ”  C  ' A G A33GCAG AC G T T  AC X  C X A X A  TCXGCT A  G • C A  G\T - O X  T  AC —  i — G 0 3 X  - X  G TC X  G X  —  X  C O X  C G C GG
(619) 619________ 630_______ 640_______ 650_______660_______ 670_______ 680_______ 690_______ 700_______ 710_______ 720_______ 730_______ 740_______750_______ 764
(618) T3AA T A TAC C CA ATA G GA TT G A X  C C - T A  X A  TA GATAAXITGATG G
(136) GTGG C G CG- G GG G X  C TG C- C G TCG G G G G  GTG X  A ---------------------- A
(765) 7 65 .7 70_______£80_______ 790_______£00_______£10_______£20_______ £30_______£40_______ £50_______£60_______£70_______£80_______ £90_______.900 910
(763) C -  ' • A ......................................................................................................................... ...............
(268) -  T
(911) 911
(908) '•n>^r.rA7P^?>^:GALATCriT3X33CGATTTT)3iXa7ITA7T3X7I»TrA3^AATO:X%^iA3jrAALi:A'TACAriT''"J>';' A
(413) C
(1057) 1057 1070 1080 1090 1100 1110 1120 1130 1140 1150 1160 1170 .1180 1190 1202
(1054) T G • T G C C  -  G
(559) C A A • A A -  C
(1203) 1203 .1210 .1220 .1230 .1240 .1250 .1260 J.270 j.280 .1290 ,1300 .1310 .1320 3330_________1348
(1199)GA A GTC X .  G G'T' X  G <JT AT G TG
(703 JAG -  T X  X  T -  A TT -C  A CA C C -
2. b) 158A1 /A2_13_R/plJ778
Figure 29. DNA sequence obtained from sample 13 (figure 21. a) (putative double mutant for 
CYP158A1 gene), from the right side (using forward primer 158AlconFl) (1) and from the left side 
of the gene (using the reverse primer 158AlconRl) (2), aligned with the chromosomal DNA sequence 
contained in the cosmid 8F11 sequence (a) and with the spectinomycin cassette sequence contained in 
pIJ778 (b). The coinciding bases are shown in red.
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(19072) 19072 .19080 .19090 ,19100
8F11 (19072)AT OGOC 
168A1/A2_21_F (1) — TATA
,19120 .19140 ,19150 191 .19170 .19180 .19190 .19200 19213
AACTACA C
agcac TGaoaswr-GGSDijrro: b x e o  *  T/iv.'T- snx n  i.o.T;n?rGjp.x^.^c>^7:^.Tn':.i.iAV'.7;u^Trn^:v:T'.vGw;<%7A>-oj.- n
1197141 19214,19220 .19230 .19240 ,19250 .19260 .19270 .19310 .19320 .19340 19 3 55
,19370 .19380 .19390 .19400 .19410 ,19420 .19430 .19440 .19450 .19460 .19470 .19480
1 ■ a ) 158A1/A2 21 F/8F11
(2065) 2065 >0 I _i 080
plJ778 (2065 )CA OCC CTT ACACTTT T TTC
168A1/A2_21_F (1) — TAT GGC CTGACGG - GGG
(2208) 2208
,2090 ,2100 2110 ?120 ?130 ,2140 ,2150 1^70
(2208) T CA GT G G
(132) A  TC C - A  A
€T TA AA TA TG TCCDXG • C CA A  TOG AT C G
GG G3 TG GC GG ------------------G GG G G— — -  A
(2351) 2351 .2360 2370
(2351 ) C A  C
(262) G G
1. b ) 158A1 /A2_21_F/plJ778
(25487) 25487
8F11 (25487)0303 GGCC G3C T
168A1/A2_21_R (1 ) --TT  TATG CAG
(25632)25632 25640 25650 25660
(25632)
(143)
CT CCAG TG2AG 
i TC TGTA GCTG A
G GCGCGGAC CCT A  A GGT 
• TT----------------AAA T  C ATA
(25777 )C—  G A C  CT CA G -G G: G CGA AG -  G C CTOZ CG G GAG
(280)AAT A  T  G AG G- C T  T  A TTG GA TAG 'IT  . G—  TC C TTT
(25922)25922 25930 25940 25950
,25820 ?5830 .25840 25850
G GGCGX GGCC C G T03GCC G CGCGPGC G 
T TAGAGA TAGG A T  GGAATA A TTATGAG T
25890 25900 2591B5921
(25919)GAAG C CC GGTC G T  GGC C A  T .C A  A E  A GC G T AC G CGTGCD G C CG
(414)CTTCA AT 7£DG T A  ACT G C . C G C C - -  C T T C C C T  A AT C T T -C T  —
CTGGAD3 a r c .  G CG - 
A-------- A  T T  G . > T TT C
GGC. GG CC .CC C GCGGT GAGA C G GCA A 
CTG C -  TA AT A  TTAAC ATTG T - ATT -
26080 26090 £6100
2.a)
(26063 >;*POG-'PJ< 
(546) TA A A
158A1/A2 21 R/8F11
26120 26130 ^6140 .2620
PU778 (469)GXAT C A G T  CA T TT G AA GG A T G T C G  CTCT C IA TA O A  T G  A G  GAT G TG AA 
168A1/A2_21_R (1 )—TTG AT C A  GG -  AG T  CT AC GC C C G A ACG C GC- G  - C A  G-T - <XG T A C - - -
(615JCC TGAAT A TAC C CA ATA G GA TT G A G3 C C- T A  CGA TA GATAAjCTTGATG G . •■•TATmTTMMjAA.’ ■
(131)03 GIGGC G CD- G GG GCG C TG C- C G TCG GGG G GTG GG A---------------------  A
.800 .820 .830 .860
(760) C -  G G
(283)AACrr-ATGA3CrWXAATCGAriD3'.T^3^31.^T7lTATTn;iX''3A.T7V.vriT>Tr-y\T'T' ^^v.T T T ^^7 IA 7?> ;A A A A m TTV .™ n73A Triv3 .13 i^G A 3303^O TvrncrTCIT'3I\3^A3ATAACrTrr
.920 ft30 .970 .990 A000 ,1010  ,1020 ,1030
(905) G AG CG A G G G  C -  T - CG GAC T AGCA T A CD
(408) A CC AT T T A  A A T  G T AA TTT C TTGT G -  AT
(1053) i m  M L
(1049JCG CCAGITDG3CXDCGATITCCATAG37ITAAGGTTTCATTrAGXCITIXZAAATTV^ATariXTITGAGGAAXXiGAIX^AAAGAjniXTCCIiXGCIGGAXTAXAA3XAADCTATGTTCK7TTGJITT1 DITAGCAAGATA
2. b) 158A1/A2_21_R/plJ778
Figure 30. DNA sequence obtained from sample 21 (figure 21. a) (putative double mutant for 
CYP158A1 gene), from the right side (using forward primer 158AlconFl) (1) and from the left side 
of the gene (using the reverse primer 158AlconRl) (2), aligned with the chromosomal DNA sequence 
contained in the cosmid 8F11 sequence (a) and with the spectinomycin cassette sequence contained in 
pIJ778 (b). The coinciding bases are shown in red.
The sequence obtained from the DNA fragments amplified by primer 
SpecIntF (annealing inside the spectinomycin gene) and 158AlconRl (figure 21. b) 
was also compared to the chromosomal sequence contained in the cosmid 8F11 and 
the spectinomycin cassette sequence contained in the plasmid pU778 (figures 31 to 
34). There is coincidence between the sequence of the samples and the sequence of
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the spectinomycin cassette up to the position where the sco6998 coding sequence 
ends.
The sequence obtained from the left side of the fragments obtained coincides 
with the chromosomal sequence up to the end of the sco6998 reading frame. From 
that position these sequences coincide with the sequence of the spectinomycin 
cassette.
41530 41543
8F11 (41399K3AC T TCT A
168A1_3_lntF (1 )—A G —A
(41544) 41544.41550 ,41560 41570
(41544 )A TCG CC T0GATGG33 C <7T TTC TG T  AAG3TG OG GG CTT ' GOC G T CA CPC GGTCA A G33GCG00G TG O G  ' G C A  G CG GT
M33) T ATC GG ----------------- T AA GAT AT -  CTAAAT AA A A -----  ATG A COT - - -  -------- T ----------------- AA GTA C T G T T C  —
41820 41833
1 . a )
(41689) TGCTI> vNG TTG G IG \ XS T(
(246) ATT C GCC T A  A -  T A -
158A1 3 Int F/8F11
<31121 3112 3120 ,3170 ,319 0 ,3200 ,3220 ,32 30
pi J778 (3112 )TTT GA A G A  A T
168A1_3_lnt_F C I - A T G G  T -  C
_^2 70 _ .3320
- | . b )  158A1_3Jnt_F/plJ778
(25480125480 25490 25500 2551 25610 25624
8F11 (25480c rc e r  • CGC GGG CC -  G GAT 
168A1_3_R(1) —AAG ATA TEA TA T T CGA
(25625)2562^5630 ,25640 ,25650 ;>5660 ,25670 25680 2^690 25700 ^5710 ,25720 25730 2^740 ^5750________ 25769
(25 6 24 )’ CT COG TOGA G A  G GCG33GAC CCT A  A  GOT G G333TC G3CC C G TCG3X G OXGAG
(144) TC TCIA G7TG A T  T  AAA T C ATA T TAGAGA TAG3 A T GGAATA A TIATCA
(25770) as.] ?q sim sim_siml zzm nm ss.gqp Siam 25950____ nm,
2. a) 158A1 3 R/8F11
plJ778 (458JTCEC C T GXA TCA G 
r a i  i  p  ( U - -A A G  A TTAC PGT C "
OACT TOG AG 
ACGAG GCT -CC
GAT T 3 3 3 G 3 T T  GCEA T  •. OCA T G  A G
CCG  AG A G CGGC G  C A  C T
A G3TT C A3 O C  PC T  
G TCD3 G G C  03  C
(604)TAAA A G O Z  TGAA T A TAC C O  ATA G GA TT G A
(129JCGG C G CGG GTG3 C GCG- G G3 GCG C T G C - C G
(749) c  G C  A -  C G  G O T
(261 )TT l>3AA.TA)AA_TC-AT3AOrn.A3;rjATTO7IX>3TOAO:73C.OT'7ITnTIGOaW.TA37rT>3rOTKP;'TO:TTT.'A_-TrAA^3:
2 .  b )  158A1_3_R/plJ778
F i g u r e  3 1 .  DNA sequence obtained from sample 3 (figure 21. b) (putative single mutant for 
CYP158A1 gene), from the right side (using primer SpecIntF) (1) and from the left side of the 
amplified fragment obtained (using the reverse primer 158AlconRl) (2), aligned with the 
chromosomal DNA sequence contained in the cosmid 8F11 sequence (a) and with the spectinomycin 
cassette sequence contained in piJ778 (b). The coinciding bases are shown in red.
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8F11 (637)CP3G TOC TACT Q3G C O SC  GOOG GCPPi CT C Gfc 03X01X3 G G C ---------TOS T * C  K  ■ C' OW7DC ----  T T M C  T— ' C . C
158A 110 IntF (1) —AA <3 AT CGA A T CT G OG   * 'CPGC PC A G O  TTCflOCT T T A AAAA CAA A  A  TA G GCCTT33 PGG A  • G CG A  PPC ".TA T
(781) 781 790_______£00_______£10______ £20_______£30_______£40______ £50_______£60______ £70_______£80_______£90_______£00_______£10_______ 924
(772)T A C  G G G CC C C C  TCE G 033TG C C  A  GC C -  G T TT TC T  C CTC GOJ3K CC 033 GT G' AT T  O X  AT GT33 TCIX33 A3 A
(139)C G T TGftA A  T AT T -  G PA- A  A  T A  C A T G A T G  CC CT G G GA- AAATG A3 GOT PC T  CG A  TIG TA A  CA7IA CC G
(925) 92 5 ,9 30_______£40_______£50______ £60_______£70_______£80_______£90_______.1000 .1010 1020 .1030 1040 .1050_________ 1068
(912) TTCC T3 C T C -  A C  C C C T C A  C PC PPC T G- TflCTC T 'ZA CG GT CC T3A GT G GC -  CIC CC — G C C *IG CGA TCG TC
(273) AAAA <33 G A  GA T G -  TCG A  T G 03 033 C CA A G C AT TT AA T A  PG T TT A  AGA PA GA C T G  CT G33 ATA G-
(1069) 1069 .1080 .1090 .1100 .1110 .1120 .1130 .1140 .1150 .1160 1170 .1180 .1190 1200 1212
(1051) CCIGTC CI3A3 G A  C T G  G3PC C  G3A G33 C G C  AG G
(409) G3AA PG T X E  A T '  A  AA CPCA G ACITT CTT AAT A A G  GT T
1 . a ) 158A1 10 Int F/8F11
p(J778 (3106)0? TT ( S K  A T
158A1 10 ln( F <1>—a ®  T  -  £C 3«£5m 7n(3?lG BO W W S3W 5e¥C M W 333nS!C T R 33IK I3rcX K »33
(3252) 32 52
(3252)(13ljT7.i33n5KT®¥iaWi«rcwni3M3M3IWOT»WC:TlWV3C7l«lia3A)CTrM^
(3396) 3396
(33 96) G G G A  T
(282) A T A
(3540) 3540 .3530 .3560 3570 3580 3590 3600 3610 3620 ,3630 .3640 3650 3660 3670 3683
(3540) G G - G G G  CT) GG AG7T G3C A  : G T O03TIC C AGPCC7)!ri733CI13)GCICT1£rGAAGn7IXCIAriCC131AGITOCTA!ITCTCTJ¥3)AAGT3)XAC3?)ACriCGAAGCT)GCIOCT'C3X'iy)CT'CTl'ICT\ 
(426) TA JC7VYVAIXW RT 7) 33CTTOC ITCWTD A  A  OTaST-TT-------------------------------------------------------------------------------------------------------------------------------------------------------------------
•j 5 ) 158A1_10_lnt_F/pU778
(25487) 23487_________fSSOO 23310 25520 )g5S30 23540  ,25350 8 3 3 6 0  ,25570 Z53B0 8 3 5 9 0  ^ 5600  ,25610 2562025631
8611(25487)03 G C  G C Q G T  , .
168A1_10_R H I - -  T T  C G  T T  -
(25632) 25632 23640 25650 25660 25670 25680 25690 25700 25710 23720 25730 25740 25750 25760 25776
(25632) CT CCTG TGCT
(143) . . I - -   T V  i       , TCTSTAGCK
— trnv
2 . 3 ) 158A1 10 R/8F11
PU778 |466)TTG (XAT A 0G A  CT TGG A3 GAT TCCG GC T T GCTA T 0 3 )  T G  A G  GAT G 173 AA TTAA TT03 T M  A GGTT CAG 083 A T T  TAA A  A
168A1.10.R t ’ ) — OGTG C C TA G,G- GCT ACE CCQ  AG A  G CXJ3C G  C A  O T -  CCG--T AC —  ,  G CD0C -03 G T0O3 G ( E — ( D C  O J3 C  O
(612) 612_____.620_______ 630_______£40_______£50_______£60_______£70_______£80_______£90_______ 700_______.710 .720 .730 .740__________ 757
(612) Q 0 3  TGAA T : A TAC C CA' ATA G (A  TT G A  G3 C C -T  A OGA TA CMAA3CITGAT73 G
(128) CGG CTQ3 C G CG- O 83 1 U33 C T G C - C  O TCG GGG G-  GIG G3-A--------------------------------------- A
810 .820 .830_______ 840_______£50_______£60_______970 880
(757)AQ3AACTTCAT'3AOCTC?G:iOAT-33A'I'')G03AC-I)jCAT''I'-ATTT7.''7VJ.TA.'.TT')7r V T T 'G X TTT ‘0«:i7rA7ri33A7)AATT:TTC'0)Ai7!-'?vTCr'TO3X73>G3COAj7»T!.3T:7T:3T'3TCOAVT.AAJ (260)A3iAA.^-ATi.V8:CTJ)33OVlT03ACTG333A(yj33CAT.TT7(nT3XCKTA3CIT37n3ATrrO3XTTI'A37rATr33A6AAATT'.TT3O)A^3M\CrG33:OCGA3333)AG33Mi:TTCTT';TT7KiOA3)TAA;;
.1020
(902) 7Ti7PTA3-TT:2A'"rai3A7313CIGArACT333OT3^3H3rirEATO'73CA3T7):/^.7VlCAT'i:TT3377373ATTTT33033rTA7ITO>.TGTA(XAAATaTO37OVajrAAG37:TACATTT77'ICATX
(405)
11048) A .-.7IT>7ATA»3rTAAG3TTT.'ATTTAa33.7n)3)AATA3AT3rrG
(5511 C •• .'•33;\AiTT?7)TAO7ITAA33!Tri3WTT3V»X7.,B'»AATA3A0CniJIT3<3«A3333A'rcAA«P*-
2.  b ) 158A1_10_R/plJ778
F i g u r e  3 2 .  DNA sequence obtained from sample 10 (figure 21. b) (putative single mutant for 
CYP158A1 gene), from the right side (using primer SpecIntF) (1) and from the left side of the 
amplified fragment obtained (using the reverse primer 158AlconRl) (2), aligned with the 
chromosomal DNA sequence contained in the cosmid 8F11 sequence (a) and with the spectinomycin 
cassette sequence contained in pIJ778 (b). The coinciding bases are shown in red.
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(35152 )35152  35160  35170  35180  35190 35280  35295
8F11 (35152)33 GT PPCT 
158A1/A2 13 Irt * 1 ) —  TO 030*
CC.GXG GG GD333CATr&-
TO AST T — TMUI'IC PG CA
T C G  03 31 03  PC ■ <33 03 AA 03 TOD3 QXT C T CGPCT C AZAT A C  G G : C ACC 003CA C G 
A G  T PCKTTC^CT TA CT CT A - PPPP. PPGP. -  A  TAX T CT1G T G C A  G 033 GAPCT T T
(35296) 35296
(35295X3 Q C  03  G T C ----------  0333 T <33 03103 OCT G -  GG CT- -
(139 A  C G TO T AA ART ATTT -G  CG TAPAT APC T  A  TA GAA G
(35440) 35440 35450 .35460 .35470 35480 ,35490 35?
A  C C3TO G C  T AXDG C P033 GC CG TCA G C G0C <333 T T 0003 T C
C A  TO3 T G A  GAPAT A  — TA C7TT T A T T -  TPC G G  A7IA C C
10 35510 35520 35530 35540 35550 35560 35570 35583
(35433) <3333TOT ' O T POZ G T  CT G CT TCOCC-C A  GTTTT <3)TO C— G 'IQ  TT T  C :
(276) AAICQOG G A  GAT T G TO C AC G A — T A  C  CCCPG ATOP. TCA A  T AA C A  •
03  T  G A -  TX333 G A  C C TOG C GT . • C  ■ PPG&C -
P G C  A  TT A A A 3 T T T G ------  T  CC A )  TCACTT C
(35584) 35584.35590 ,35600 ,35680 35690 .35700 .35710 35727
(35573) CG TG G GDG OC C ‘ 
(415) A3 AC C C IA  AA A
1- a ) 158A1/A2 13 Int F/8F11
(3 1 1 0 )3 1 1 0  3120
pU778 (3110)AKTT A A  A T
15«A1/A2_13_lnt_H1) --AA GC. O
(3250) 3250
(3250)
(138)
(3390) 3 3 9 0  .340C  .341C  ,3 4 2 0  ,3 4 3 0  .344C  .345C  .3 1 6 0  .347C  .348C  .3 4 9 0  .3 5 0 0  ,3 5 1 0 ___________3 5 2 9
(3390) • «  tXaaaaaCTTCBMCTASaOXTTM  G G T  G G f f i  G G G
(276) A T G  T C A G C C C
(3530) 3 5  3C .3 5 6 0  .355C  3 5 6 C  3 5 7 0  .358C  ,3 5 9 0  .360C 3 6 1 0  .362C  3 6 3 0  .364C J 6 5 C __________ 3 6 6 9
(3530) TTIOT or A AGS A3«C AraVO TA3ia3M JW aw 3A(racn3C]nXX343Ta3ArraiTC KrT3!I131A3ITO C IAri033iAG T^^
(418) a n : -  ’ . .  C m a a  t c c -  i  < r ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
1 .b ) 158A1/A2_13_lnt_F/pU778
(25484) 25484 25490 25300 25510 25520 25530
8F11 (25484 )TG C G CC C (MAT
168A1/A2.13 R f f l  —I G A  «  A T -A
(25829) 23629 )Z5640 ,25650 25660 ?5670 25680 ,25690 25700 ,25710 25720 ^5730 p5740 ^5750 25760 23773
(25629) CTOAGTG CAG A G QCS333AC CCT A  A GGT G GGCQX GGCC C G T0GGCC G GG0GADC G
(142) TCTGTAGCTOA T T ----------------AAA T C ATA T TA3AGA TAGG A  T GGAATA A  TTATGAG T
125774) 25774 (25780 ^5790 ,25800 ,25810 ^5820 ^5830 ^5840 ,25650 ^5860 ,25970 ^5880 ,25890 ^5900______ 25918
125774) C— G A C  CT CA GAG G G CGA AG - G C CTGC CG G GAG GC 0333 C G . G Q G G  CCT OCCTAraX GG G TTGGGGT C T C GT G03G C GG
(2791 AAT A T G  A 3 G - C T T A T T O  GA T C T  G TC C TTT T A  G C A TC T AAC ------------------- TC ■ C -------------  A  C  A . —  CTTC T TT
(25919125919 25930 33940 25950 25960 25970 25960 25990 26000 26010 26020 26030 26040 26050 26063
(25916IGGGG CCTC GG (M G  0G0DGC G C . -  A f f i C  C  C IU C G C
(398)--- G VG W G  C T T  TA-C H  A  TAT , 03  G TG'T ' T .  G -C G C A
(26064) 26064 26070 26080 26090 26100 26110 26120 26130 26140 36150
(26209) 26209 ^62 2 0 ^6230 ^6240 26250 ,26260 ^6270 26280 )26290 26100 2 6310 j>6320 26330 ,26340 26353
(26202) : G GGXTOCGT QGCOGAC O KGGCT GGCG3CE S - O K J G  AOGT CC ■ C  ajCTG 030335030303 C GT GGTGATOCAXOGTAa^MXU J jl 'TIG G gm rrayX G O O T
(6551 T CAAG3AAAG AtrGTTCT T  TTTTGr AAGATAG A . TCAT TC GGTG TG - T AAAAA TTTAACAATAIC T O T  C------------------------------------------------------------------------------
2 . a )  158 A1 /A2_13_R/8F11
(473) 473 480_______ 490_______ 500_______ 510_______520_______ 530_______ 540_______ 550_______560_______ 570_______580_______590_______ 600___________ 618
plJ778473)TT A  T  C CAACTGT 03 A G  —  T TG G CCICTT CTAdTAC C A  T G  A G  « T  G TG AA TTAA TTG3 TAA A  GGIT C J G O C A C T  TAA A A G CG
168A1/A2 13 r ( D - -  C A G  AD33CAG AC G T T C OC C  Q3AGCA TCCGGCT A G  C A C T  CCG T AC —  G OXC -CC G TOOG G GC - - -  CG C C03 C G C GG
(619) 619______£30_______£40_______ 650_______660_______ 670_______ 680_______ 690_______ 700_______ 710_______ 720_______ 730_______ 740_______ 750_______ 764
(618) TCAAT A U C  CCA AXA G G A T T G  A GGC C - T  A .  CGA TA GATAAGCTTGATG G
(136) GTGG'C G OS- G GG GOG C T G C - C  G TC G GG G G GTG GG A---------------------  A
(765) 765 .770_______£80_______£90_______£00_______£10 .820 .830_______£40_______£50_______ £60_______£70_______£80_______ £90_______ .900 910
(763) ' C • T'2V3Q^T35ACT3OTA3C13GlAT11T-ATTT07MAT-. ■ ,• AAATTCnCCAACIGAirTPT-TjCTMSAGGlXAAMlAT'Tn'-TICrT T
(2681 -  CTCASrAAJCGfCTIjG T • TTTaOSDW BMW  ■ BGI < 17iA3T*T TTTTcTTST VAAKTAAC. T T  T
(911) 911 .920_______£30_______£40_______£50_______£60_______£70_______£80_______£90_______.1000 >010 .1020 >030 .1040_______1056
(908) . . .  A
(413)TAGCnCAAGTATXAa3M7IGATACI\M3CO3MA3Ga3CTCC3l(rr(3XCA7na33^303ACATTTICBM373ATrn’GXG(7rTACr(M37TjTAXAAA!I\MI3G(jA2AA37rAitjCAITAC'AnTM7ICA,ICGCC03X
(1057) 1057 .1070 .1080 .1090 ,1100 .1110 .1120 .1130 .1140 .1150 .1160 .1170 ,1180 .1190 1202
(1054) T G  T -  G C C -  AG AA
(559) r ATAMGITATGCTTTOSrrrA > C A A  A A -  C -
(17031 1203 1210 .1220 1230 .1240 1250 .1260 1270 1260 1290 .1300 .1310 .1320 1330_________ 1348
(703)AG A-T T  T 'C n ' <XT . I T  TTW -A- "TFACvV: A  C K ' ■ C ~ C
2. b) 158A1 /A2_13_R/pIJ778
Figure 33. DNA sequence obtained from sample 13 (figure 21. b) (putative double mutant for 
CYP158A1 gene), from the right side (using primer SpecIntF) (1) and from the left side of the 
amplified fragment obtained (using the reverse primer 158AlconRl) (2), aligned with the 
chromosomal DNA sequence contained in the cosmid 8F11 sequence (a) and with the spectinomycin 
cassette sequence contained in piJ778 (b). The coinciding bases are shown in red.
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(41399) ■*1399 4 1 410  41420 41430  41440
8F11 (41399GPG3 
158A1/A2 21 Int F<1 ~ T A
TCT
G 3\
GA A  G C GEA CG TCA C C 9 3 T C T A C  G OXT TPG C G T T C T C f t A C  O  GC OC7IC / C  G2GPG A 
A3 ' C  T A  ATT TT CTG T T TT A  A ;  -  A  A  GMC A2A A  C G C A  CP CTT A  A A3 APGA A  AEWT T
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(25922) 25922 25930
(25919JGAA3 C GC GGTC G T  GGC C A  T O A  AO? A OC G T AC G 0 3  TGCG G C CG CT0GA33 OC C 6  0 3  -  
(414)CTTCA AT A03G T A  ACT G O  • C O  C C— C TT O C  CT A AT CTT- C  T  — A A T T  G T TT  C
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CTG C - TA AT A TTAA: ATTG T  - ATT -
2609
2. a)
(26063 )T '.tJ -T  
(546) ; TA: A A ----------------------------------
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168A1 /A2_21 _R (1 )—TIG A T C  A  GG -  AG T  CT AC GC C C G A AOG C GC- G  C A  C T  (333 T A C —   G OCX -CC
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{760) AA7irOOlGA3CTGAGGCAATOGATIGGClGAGCOGCATCT-ATnGGCX]ACTAXTPGTPGATCT03JCTCTCAOjIACTGjA3WQ’ TCTrOCAA7P 3KTCT3OG0GOSM3 3 TIAA 3 ~GrT ■ TT .TT  CTP T  3 M  G
(263) T C C
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F i g u r e  3 4 .  DNA sequence obtained from sample 21 (figure 21. b) (putative double mutant for 
CYP158A1 gene), from the right side (using primer SpecIntF) (1) and from the left side of the 
amplified fragment obtained (using the reverse primer 158AlconRl) (2), aligned with the 
chromosomal DNA sequence contained in the cosmid 8F11 sequence (a) and with the spectinomycin 
cassette sequence contained in pIJ778 (b). The coinciding bases are shown in red.
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These results show the sequence of the junction between the spectinomycin 
cassette and the adjacent region of the sco6998 locus in the mutants, showing 
coincidence with the parental chromosomal sequence at the flanks of the locus, and 
with the spectinomycin cassette inside the coding region. Only the sequence from the 
smaller band for sample 3 showed coincidence with the chromosomal sequence all 
along its length. A single cross-over is likely to have occurred during recombination 
for this mutant and the gene deletion was unsuccessful. Further corroboration by 
Southern blotting is required for validation of mutations.
3.2 STUDIES ON PHENOTYPE OF THE MUTANTS COMPARED TO 
THE PARENTAL STRAIN
Spores of the parental strain, the putative single deletion mutants for the 
CYP158A1 gene, and the putative double mutants for both CYP158A1 and 
CYP158A2 genes were inoculated in liquid and solid media in order to detect any 
differences on phenotype. These studies were in parallel with the mutant verification 
studies. Samples of isolate 3 were included in this analysis although the deletion of 
the gene sco6998 was unsuccessful as indicated by PCR analysis and DNA 
sequencing. Further phenotype studies reported below were undertaken using the 
mutant strains as described although more validation is still needed.
Cultures in liquid medium (YEME):
After 7 days of incubation cultures in YEME medium were observed to 
detect any changes in phenotype. The cultures were checked everyday for any 
appearance of colour in the medium.
No differences on phenotype with respect to the wild type strain were found 
in any of the samples (figures 35 to 37).
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F i g u r e  35. YEME cultures of wild type and putative single mutants for CYP158A1 after 7 days of
incubation.
F i g u r e  3 6 .  YEME cultures of wild type and mutants for CYP158A2 after 7 days of incubation.
i!58A 1/A 2_21 .1 58A 1/A 2_13)
F i g u r e  3 7 .  YEME cultures of wild type and double mutants after 7 days of incubation.
Cultures on solid medium (MS plates):
An aliquote of spores was inoculated in MS medium plates which were 
incubated for a week. Four control plates were also set inoculating parental spores in 
MS medium plates with and without apramycin (50 pg/ml) given that the deletion of 
the CYP158A2 gene was performed by replacement with an apramycin resistance 
cassette and spectinomycin (400 pg/ml) because of the spectinomycin resistance 
cassette used to replace the CYP158A1 gene (figure 38).
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Figure 38. Spores of wild type and mutants inoculated in MS plates, a) Control plates. Wild type 
spores were inoculated in MS plates with and without antibiotics (CYP158A2 was disrupted with an 
apramycin resistance cassette), b) Spores of the putative single and double mutants for CYP158A1 
and spores of the mutant for C YP158A2 inoculated in MS plates with their respective antibiotics.
No significant differences were detected in the phenotype of the single 
mutants for the CYP158A1 and CYP158A2 encoding genes or of the double mutant 
for both genes in comparison with the parental strain in solid medium.
According to these results, deletion of the gene sco6998 encoding for 
CYP158A1, of the gene scol207 encoding for CYP158A2, or deletion of both genes 
in the same strain, does not seem to have any effect on the phenotype in the 
conditions tested.
3.3 UV SENSITIVITY ASSAYS
The results of the spore survival analysis after UV irradiation are shown in 
figure 39 and table 2. The percentage of spore survival was calculated as the ratio 
between the colonies that appeared after 2 days of incubation after UV irradiation 
and the colonies that appeared at time 0, without any UV treatment.
68
Dose (sec) wt A158A110 A158A2 A158A1/A213
0 100% 100% 100% 100%
5 27 3.37 98.28 94.38
10 37.3 5.42 91.43 93.97
15 32.2 4.94 74.35 94.78
20 18,6 4.19 81.18 97.11
30 17.5 3.46 57.25 66.26
40 18.04 3.99 63.23 69.39
50 9.8 4.04 36.74 72.33
60 4.29 1.66 36.74 59.98
T a b l e  2. Percentage of colonies that survived after UV irradiation compared to the colonies that
appeared without irradiation.
Wild T#)e100
90
CYP158A2
80
70
50
Q. 40
30
20
10
0
0 10 20 30 40 50 60
Figure 39. Spore survival after UV irradiation. Dark blue: parental strain. Pink: single mutant for 
CYP158A1 gene. Yellow: single mutant for CYP158A2 gene. Light Blue: double mutant for
CYP158A1 and CYP158A2 genes.
3.4 MASS SPECTROMETRY
Liquid chromatography-coupled Mass spectrometry (HPLC/MS) was carried 
out to detect the presence of flaviolin in extracts of cultures inoculated with spores 
from the parental strain, the single mutant for the CYP158A1 gene, the single mutant 
for CYP158A2 gene and the double mutant for both genes. The spectra obtained are 
shown in figures 41 to 44.
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Several compounds were initially separated by chromatography from each 
sample (showing as peaks in the chromatogram). These compounds were subjected 
to mass spectrometry and their mass spectra were extracted.
The mass spectra of the most relevant compounds detected (i.e the most 
abundant ones or the ones showing a peak with m/z value similar to that of flaviolin, 
figure 40) are shown in the figures below. The molecular mass of flaviolin is 206 
amu.
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Figure 40. Flaviolin HPLC/MS spectra obtained in the same conditions as the samples. The top figure 
shows the total ion chromatogram (TIC) of the flaviolin eluting at 13.89 minutes. The figure at the 
bottom is the mass spectrum for this molecule which shows a base peak at an m/z value of 206.80
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Figure 41. Total ion chromatogram (TIC) of the parental strain sample. Different compounds (peaks) 
were separated by HPLC eluting at different retention times. The figures 41 .A to 41 .K show the mass 
spectra of the peaks labelled in the chromatogram.
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Figure 41 .A: Mass spectrum of the compound eluting at 10.58 minutes.
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Figure 41.B: Mass spectrum of the compound eluting at 12.06 minutes.
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Figure 41 ,C: Mass spectrum of the compound eluting at 13.16 minutes
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Figure 41 ,D: Mass spectrum of the compound eluting at 14 minutes.
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Figure 41 .E: Mass spectrum of the compound eluting at 15 minutes.
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Figure 41 .F: Mass spectrum of the compound eluting at 16.13 minutes.
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Figure 41.G: Mass spectrum of the compound eluting at 17.81 minutes.
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Figure 41 ,H: Mass spectrum of the compound eluting at 18.98 minutes.
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Figure 41.1: Mass spectrum o f the compound eluting at 21.31 minutes.
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Figure 41. J: Mass spectrum of the compound eluting at 23.06 minutes.
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Figure 41 .K: Mass spectrum o f the compound eluting at 25 minutes.
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Figure 42. Total ion chromatogram (TIC) of the single mutant for CYP158A1 gene sample. The 
figures 42. A to 42.F show the mass spectra of the peaks labelled in the chromatogram.
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Figure 42.A: Mass spectrum of the compound eluting at 14.87 minutes.
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Figure 42 .B: Mass spectrum of the compound eluting at 16 minutes.
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Figure 42.C: Mass spectrum of the compound eluting at 17.71 minutes.
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Figure 42.D: Mass spectrum of the compound eluting at 21.4 minutes.
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Figure 42.E: Mass spectrum of the compound eluting at 23.03 minutes.
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Figure 42.F: Mass spectrum of the compound eluting at 24.92 minutes.
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Figure 43. Total ion chromatogram (TIC) of the single mutant for CYP158A2 gene sample. The 
figures 43. A to 43.G show the mass spectra of the peaks labelled in the chromatogram.
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Figure 43 .A: Mass spectrum of compound labelled as A.
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Figure 43 ,B: Mass spectrum of compound B.
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Figure 43 .C: Mass spectrum of compound C.
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Figure 43.D: Mass spectrum of compound D.
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Figure 43 .E: Mass spectrum of compound E.
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Figure 43.F: Mass spectrum of compound F.
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Figure 43.G: Mass spectrum of compound G.
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Figure 44. Total ion chromatogram (TIC) of the sample of double mutant for CYP158A1 and 
CYP158A2 genes. The peaks (compounds) obtained are the same than the ones obtained for the 
CYP158A2 single mutant. The mass spectra are shown in figures 43.A to 43.G.
None of the mass spectra obtained from the different compounds detected in 
each sample (parental strain, deletion mutant for CYP158A2 gene, deletion mutant 
for CYP158A1 gene, or deletion mutant for both genes) showed the typical flaviolin 
mass spectrum (figure 40).
Flaviolin is apparently not being accumulated in the cultures of the parental 
strain or any of the mutants.
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SUMMARY
Deletion of the gene sco6998 encoding CYP158A1 to create a single mutant 
and a double mutant for CYP158A1 and CYP158A2 genes was attempted following 
a PCR-based methodology. PCR screening and sequencing of the junctions between 
the inserted spectinomycin cassette and the adjacent regions of the locus sco6998 
were performed in order to investigate the gene replacement. The results suggest that 
the introduction of the spectinomycin cassette replacing the gene encoding for 
CYP158A1 were successful in three of the mutants screened, although this event was 
not confirmed by Southern Blot analysis so far.
No differences on phenotype were observed in the conditions tested between 
these mutants and the parental strain when culturing them in liquid and solid media. 
The mass spectra obtained from extracts of those cultures showed no resemblance in 
any case with the typical flaviolin spectra. However, it is noteworthy that the 
chromatographic profile of the single mutant for CYP158A1 was similar to that of 
the parental strain and the chromatographic profile of the single deletion mutant for 
CYP158A2 gene resembled that of the double mutant for both genes.
Deletion of the gene sco6998 encoding for CYP158A1 in a single mutant 
decreased the viability of spores subjected to UV radiation treatment. Deletion of the 
gene encoding for CYP158A2 showed increased resistance of spores to the same UV 
treatment compared to the parental strain. The latter phenotype was also detected for 
the double mutant for both of these genes.
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4 DISCUSSION
In actinomycetes PKS and their related cytochromes P450 are enzymes 
involved in synthesis and modification (respectively) of different polyketides. These 
modifications usually provide the special biological properties of these compounds 
(pigments, antibiotics, immunosuppressants).
CYP158A2 from S. coelicolor A3(2) is an enzyme with monooxygenase 
activity which is encoded within a three-gene operon together with a polyketide 
synthase (THN synthase) and ORF3. This THN synthase catalysis the formation of 
THN from five molecules of Malonyl-CoA, which is then oxidised to flaviolin. The 
role of the CYP is the biosynthesis of pigments for the protection against UV 
irradiation which achieves by oxidative coupling of two molecules of flaviolin.
CYP158A1 also uses flaviolin as substrate to yield the same products and it 
has been thought to be substituting CYP158A2 in function in a mutant with the gene 
for this enzyme deleted. The disruption of the gene rppA, an homologous of THN 
synthase of S. coelicolor in Streptomyces griseus and Saccharopolyspora erythraea 
led to the production of an albino phenotype. Given that, the same results were 
expected to be obtained when disrupting CYP158A2 gene (scol207) or rppA 
(scol206) in S. coelicolor. However, these gene knockouts resulted in no changes of 
phenotype (Izumikawa et al., 2003;Funa et al., 2005a;Zhao et al., 2007). In the 
myxobacterium Sorangium cellulosum, a gene for a type III polyketide synthase was 
inactivated, and the mutant showed no physiological difference compared to the wild 
type strain (Gross et al, 2006). This is why it has been suggested that these genes are 
silent, or that may not be expressed under normal growth conditions.
In S. griseus, RppA (THNS) is involved in production of HPQ-melanin, 
synthesized by the P450mel from THN. In other species THN is converted by 
MomA (quinone-forming monooxygenase) into its quinone, flaviolin, which is 
modificated by CYP158A2 in S. coelicolor to produce dimeric and trimeric red- 
brown pigments. In S. erythraea (red variant) flaviolin derivatives are synthesized to 
be incorporated to the red-brown pigment they typically produce.
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The aim of this work was to try to corroborate the role of CYP158A1 as a 
substitute of CYP158A2 in the biosynthesis of those flaviolin-derived pigments. This 
hypothesis was tested by generation of two different mutants, a single mutant with 
the gene for the CYP158A1 disrupted and a double mutant for both CYP158A1 and 
A2. REDIRECT technology was used to this end as it is a well described and adapted 
method for S. coelicolor.
Typically, around 10% of the exconjugants obtained by the REDIRECT 
technology are double cross-over recombinants (Gust et a l, 2002). In fact, 12 out of 
104 exconjugants obtained for the single mutation and 14 out of 116 for the double 
had the correct phenotype.
Streptomyces cosmids contain two different antibiotic resistance selective 
markers, an ampicillin resistance gene and a kanamycin resistance gene. Kanamycin 
resistance is usually used in these experiments as the selective marker. In this work, 
however, a high concentration of ampicillin, at which the parental strain does not 
grow, was used to screen exconjugants for the antibiotic resistance phenotype.
Southern hybridisation experiments were carried out with samples from four 
of those exconjugants in order to confirm the deletion of the gene sco6998. 
Conclusive results were not obtained in the time available by this method given that 
it was not possible to obtain enough signal for the control sample (parental strain 
DNA). The quantity of genomic DNA of the samples and the probe DNA was 
measured by spectrophotometry and proved to be sufficient. Its quality, measured as 
the ratio 260/280 was as well acceptable. Several variations were therefore done to 
the method used to try to optimise every condition to obtain a good signal in the 
membrane. However, none of these approaches was apparently enough to obtain a 
good resolution of bands.
BamHl was the restriction enzyme used at the beginning of this work to 
digest the genomic DNA for the experiment of Southern hybridization. A BamYR 
recognition site exists inside the gene sco6998. As this gene is cut during the 
digestion of the genomic DNA, the probability of hybridisation with the DNA probe
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(which is the whole gene sco6998) is reduced. Apal was therefore used as an 
alternative, more appropriate restriction enzyme to digest the genomic DNA. 
According to the restriction map obtained, this enzyme does not cut inside the gene 
nor the cassette producing a digestion fragment in the wild type of 1783 bp.
Depurination of the DNA in the agarose gel after electrophoresis and before 
washing it to transfer the DNA to the membrane through the Southern blot aids in the 
posterior denaturation step. However, this step should only be used when target DNA 
fragments exceed 15 kb (Sambrook and Russell, 2001). Given that our target DNA 
was 1783 bp long, that depurination step might be breaking the DNA molecules too 
much causing the fragments that go through to the membrane being too small to be 
retained (Sambrook and Russell, 2001). Therefore, after several vain attempts 
depurinating the DNA before the denaturation, this step was eliminated. This 
approach was nevertheless unsuccessful as detection of the bands was still not 
enough to obtain conclusive results.
Hybridisation temperature was as well varied to increase the probability of 
probe binding to the target DNA. Stringency washes were carried out at room 
temperature to avoid the loss of the DNA already hybridised None of these 
procedures were sufficient to improve the signal in the membrane.
PCR screening was then performed to corroborate the mutation using 
different set of primers. The correct band pattern was detected for 2 of the mutants 
(10, single mutant for gene CYP158A1, and 13, double mutant for both genes 
CYP158A1 and CYP158A2). Two bands of approximately 1600 and 1700 bp were 
observed in several lanes when using the flanking primers for the gene. The two 
bands correspond to both the gene (whose amplification product is theoretically 1650 
bp long) and the spectinomycin cassette (whose amplification product should be 
1851 bp long). These results suggest that both the gene and the disruption cassette 
are inside the chromosome and therefore a single cross-over occurred during 
recombination instead of the desired double cross-over in those mutants.
As a mean to verify if a single or double cross-over occurred during 
recombination, and therefore to confirm if the replacement of the gene took place,
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PCR products from the putative mutants was sequenced. The sequence obtained for 
each of the samples was compared with both the chromosomal DNA sequence 
contained in the cosmid 8F11 and pU778 containing the spectinomycin cassette 
sequence.
Parental DNA was as well sequenced and used as a control sample. The DNA 
sequence at both sides of the sco6998 locus indeed coincided with the chromosomal 
DNA sequence and not with the sequence contained in the plasmid pU778 as 
expected.
The DNA sequence obtained from the two fragments of DNA obtained when 
amplifying with the flanking primers for the gene sco6998 of sample 3 (single 
mutant for gene sco6998 encoding for CYP158A1) showed coincidence with both 
the chromosomal DNA contained in the cosmid 8F11 and the spectinomycin cassette 
sequence contained in the plasmid pU778. The largest band showed coincidence with 
the chromosomal DNA only in the region flanking the sco6998 reading frame, and 
with the spectinomycin cassette sequence along the sco6998 internal coding 
sequence. The smallest band showed no coincidence with the plasmid pU778 
containing the spectinomycin cassette. These results suggest that this mutant 
possesses the spectinomycin cassette, as further confirmed by sequencing the band of 
DNA obtained with the internal primers for the cassette, but it also contains the gene 
CYP158A1. A single cross-over occurred during recombination of the disrupted 
cosmid with the chromosome of S. coelicolor instead of the desired double cross­
over which would lead to replacement of the gene. Therefore the deletion in this 
mutant was not successful.
The same DNA sequence similarity analyses made for the rest of the mutants 
(samples 10, putative single mutant, 13 and 21, putative double mutants) at both 
sides of the PCR amplified fragments obtained for each sample, show how the 
insertion of the spectinomycin cassette was successful. When amplifying the DNA 
with a primer annealing inside the spectinomycin cassette, bands were obtained for 
the four of them, proving that the cassette was inserted in their chromosomes. Further 
sequencing of the DNA of those bands using this internal primer confirmed this fact, 
as the DNA sequence of the mutants coincides with the spectinomycin cassette
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sequence in the region corresponding with the internal coding sequence of the gene 
sco6998. The sequence comparison of the DNA obtained by amplification with the 
flanking primers for the gene sco6998 for all these samples reveals that the fragment 
amplified is not the gene sco6998 encoding for CYP158A1 but the spectinomycin 
cassette. Moreover, in those mutants the flanking sequence adjacent to the inserted 
cassette matches the adjacent sequence to the gene. According to these results these 
three mutants seem to have the gene sco6998 successfully deleted and replaced by 
the spectinomycin cassette.
Additional results from Southern Blotting experiments are necessary in order 
to confirm the double cross-over event which leads to the replacement of the gene. 
However, time limitations did not allow the completion of this procedure succesfully. 
The replacement of the gene sco6998 by the spectinomycin cassette in these mutants 
is therefore still not completely proved.
In S. griseus P450mel is the protein responsible for the aryl coupling of THN 
to yield HPQ (l,4,6,7,9,12-hexahydroxyperylene-3,10-quinone) which polymerises 
to yield HPQ melanin (Funa et al, 2005a). In S. antibioticus the protein encoded by 
the gene momA uses THN as substrate to yield flaviolin. In other Streptomyces 
species such as Saccharopolyspora erythraea, S. avermitilis or S. coelicolor the same 
gene organization has been found, including the gene rppA encoding for a type III 
PKS, a cytochrome P450 gene and a gene similar to momA all grouped in cluster. 
The aminoacid sequence of momA from S. antibioticus shares overall similarity to 
the ORF3 (scol208) found in cluster with the THN synthase and CYP158A2 in S. 
coelicolor A3(2) (Funa et al., 2005b).
A P450mel mutant of S. griseus showed the presence of a red pigment in the 
mycelium and spores of this organism, due to the accumulation of flaviolin produced 
from THN by autooxidation (Funa et al., 2005a). The same phenotype was expected 
to be obtained in a CYP158A2 gene deletion mutant in S. coelicolor due to the 
accumulation of its substrate flaviolin. This deletion, however, produced no 
differences in the phenotype of this mutant compared to the wild type (Funa et al., 
2005b;Zhao et al., 2007). CYP158A1 was thought to be substituting CYP158A2 in 
the formation of flaviolin derivatives given that it can catalyse oxidative coupling of
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flaviolin to yield almost identical products. In this work the gene sco6998 encoding 
for this CYP158A1 was investigated to prove this hypothesis in a single mutant and 
in a mutant for the CYP158A2 gene. These mutants were cultured in solid and liquid 
medium to screen any differences on the phenotype compared to the parental strain. 
However, the expected red pigment was not detected in the mycelium growing in 
liquid medium nor in the spores growing in MS plates, and any other significant 
change was detected.
The medium composition and culture conditions are critical factors in 
obtaining a desired phenotype. The lack of differences in phenotype of the mutants 
compared to the parental strain can be due to the fact that the conditions used in this 
experiment were not appropriate as reported previously for generating the phenotype 
for CYP158A2 mutant (Zhao et al., 2007).
Apart from the genome and the proteome the study of the metabolome of an 
organism has become a useful tool to further characterise it. To this end, in this work 
Mass spectrometry experiments were carried out in order to characterise the mutants 
regarding the production or accumulation of flaviolin. The HPLC/MS experiments 
performed showed no detection of the flaviolin mass spectrum in the culture extracts 
of the parental strain or any of the mutants (single mutant for CYP158A1 gene, 
single mutant for CYP158A2 gene or double mutant for both genes). In the parental 
strain the flaviolin synthesised from THN is used by CYP158A2 and CYP158A1 to 
produce the flaviolin derived pigments. In the single mutants for the CYP158A1 or 
CYP158A2 genes flaviolin is also being used by one or the other CYP to yield those 
pigments. In the double mutant for both CYP158A1 and CYP158A2 genes, none of 
these CYPs are present to catalyse that flaviolin transformation. We assumed that the 
interruption of this pathway would lead to the accumulation of this metabolite. 
However, flaviolin was not detected in culture extracts of this mutant analysed by 
mass spectrometry. This suggests that flaviolin is not being accumulated or being 
converted into a different compound. It has been reported that flaviolin can be the 
precursor of other metabolites in other Streptomyces species. In S. antibioticus the 
product of the gene momA it has been seen to be involved in the modification of 
flaviolin to yield the pigment mompain (Funa et al., 2005b). MomA shares overall 
similarity in amino acid sequence with the product of gene scol208, also named
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ORF3, which is located downstream adjacent to the gene encoding for CYP158A2 
(scol207) and included in a three-gene operon together with scol206 encoding for 
THN synthase. According to this, the gene product of scol208 might be involved in 
the utilisation of the flaviolin in the CYP158A1 and CYP158A2 double mutant.
Flaviolin derivatives are pigments for the protection against UV exposure in 
streptomycetes. Spore survival under UV radiation was measured to check the effect 
of the mutation on this feature. However the results of these experiments do not 
correspond to what was initially expected. Hypothetically, die double mutant with 
both genes for CYP158A1 and CYP158A2 deleted might not produce any of the 
flaviolin derivatives that protect this bacterium against ultraviolet radiation. Thus, 
this mutant would be expected to present less spore survival under the UV irradiation 
treatment than the wild type. However, the overall percentage of surviving spores 
after the treatment was higher than the percentage obtained for the wild type. The 
single mutant for the CYP158A1 gene was the only mutant which showed less spore 
resistance than the wild type, presenting approximately the same pattern along the 
time with dose response as the parental strain. This result coincides with the effect of 
the P450mel mutation in spore survival in S. griseus, where the deletion of this gene 
produced a reduction in the resistance to UV irradiation (Funa et a l, 2005a). The 
unexpected higher resistance observed in the spores of the CYP158A2 mutant and 
the double mutant for CYP158A1 and CYP158A2 genes, might suggest that 
CYP158A2 is involved in the production of a compound which potentiates UV effect 
on the spores of these bacteria or could be explained by the fact that in these mutants 
another compound is being produced which might enhance the resistance of these 
organisms against UV irradiation. This hypothesis agrees with the mass spectra of 
extracts of cultures of the single mutant for CYP158A2 and the double mutant. New 
compounds were detected for these samples that were not found in the extracts of the 
parental strain or the single mutant for CYP158A1.
Functionally related genes are often located in clusters in prokaryotes. The 
product of the gene scol208, which is in cluster with the gene scol207 encoding for 
CYP158A2 and with the gene scol206 encoding for a THN synthase, shares overall 
amino acid sequence similarity with the product of the gene momA in S. antibioticus. 
MomA has been reported to be involved in the conversion of flaviolin to yield
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mompain (Funa, 2005). Given that in a mutant for the gene scol207 there is no 
CYP158A2 to metabolise the flaviolin that is being produced from the THN 
synthesised by THN synthase, flaviolin might be being used by the scol208 gene 
product to yield a different compound, presumably providing higher resistance 
against UV irradiation to these bacteria. In a mutant for the CYP158A1 gene, 
flaviolin is being used by CYP158A2 to yield flaviolin derived pigments and 
therefore that compound is not being produced and is not providing that enhanced 
UV resistance.
4.1 FURTHER EXPERIMENTS
Confirmation of the desired mutation for the gene sco6998 deletion by 
Southern blot is the first step that should be taken forward. Once the deletion is 
corroborated characterisation experiments on the phenotype of these mutants will 
shed light into the actual function of these proteins.
Optimization of Southern Blotting method is necessary to conclusively 
confirm the mutations. Several different approaches were done in this work to that 
end, none of them being successful. Other variations to the method that could be 
done are the transfer of the DNA to the membrane and the immunological detection. 
There are several immunological detection methods described, other than 
colorimetric detection by enzyme immunoassay using NBT/BCIP. One of them, 
which is probably more sensitive, is the use of chemiluminescent alkaline 
phosphatase substrates such as CDP or CSPD. When the alkaline phosphatase reacts 
with this compounds they produce light which is then detected exposing the 
membrane to a photographic film.
Once the replacement of the gene by the spectinomycin cassette has been 
confirmed, the REDIRECT technology culminates with the excision of the inserted 
disrupted cassette replacing the gene. This is achieved thanks to the FRT sites 
located at both ends of the cassette which will be recognised by the FLP-recombinase 
from Saccharomyces cerevisiae. The expression of this enzyme in E. coli removes 
the central part of the disruption cassette. However, not the whole cassette is
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removed by this action and an 81 bp scar remains in the chromosome. This sequence 
must lack stop codons to maintain the reading frame.
The use of other methodologies to achieve the deletion of the gene should be 
considered. It has been previously reported that the REDIRECT technology was not 
successful on the deletion of several cytochromes P450 genes in their containing 
cosmids in S. coelicolor (Skaug, 2006). In this case, transposon mutagenesis was 
performed to create the disrupted cosmids.
Transposon mutagenesis consists of the replacement of a gene by a 
transposon. A S. coelicolor A3 (2) ordered transposon library was constructed by 
Bishop, 2004 using transposon Tn5062, derived from Tn5, which carries an 
ampicilin resistance gene and a green florescent protein (GFP) as markers, and an 
oriT to allow the transfer into S. coelicolor by conjugation. A disrupted cosmid for 
the gene encoding the CYP158A1 from this library can be inserted in S. coelicolor 
and the positive clones selected in the same way as for the REDIRECT methodology. 
The success on this approach still depends on obtaining allelic exchange by double 
cross-over during recombination.
Characterisation of the mutants’ phenotype will be essential to determine the 
effect of gene deletion. As well as optimising the culture conditions and media 
composition in the search of the expected phenotype of the mutants, mass 
spectrometry analyses will have to be performed again to determine their metabolic 
profile regarding flaviolin production, as well as ultraviolet irradiation assays which 
will show the effect of the lack of those flaviolin derived pigments on the survival of 
the spores.
Regardless of the method used to produce the gene disruption, when the 
mutants are found to have a different phenotype than the wild type strain, 
complementation of the mutation has to be performed in order to attribute that effect 
on the phenotype to that particular change on the phenotype. Complementation 
consists of the insertion of the gene back to the cell, generally by insertion of an 
expression plasmid containing the gene, and the restoring of the parental phenotype. 
Thus, if the parental phenotype is restored the change on phenotype can certainly be
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attributed to that mutation, and the function of the corresponding protein is therefore 
elucidated.
Since the publication of S. coelicolor A3 (2) CYPome in 2002, several of 
these proteins have been studied in order to know their function. Deletion of their 
genes has been achieved for some of them, and diverse studies to characterise these 
mutants and more gene disruptions for other CYPs will be done in the future. This 
work was an attempt to disrupt and characterise one of those 18 CYPs, in order to 
elucidate its function, and thus improve our knowledge about these diverse and 
valuable proteins.
Prenylation of small aromatic molecules is an important process leading to 
the biosynthesis of diverse secondary metabolites in bacteria. Flaviolin, THN, and 
other THN derivatives have been reported to be the substrate of several 
prenyltransferases catalysing the addition of isoprenoid groups to these molecules. 
Understanding the metabolic flux of these compounds in the pathway, as well as of 
pigments for the protection against UV radiation synthesised by CYP158A1 and 
CYP158A2 might mark the importance if this pathway in the identification of novel 
secondary metabolites.
ANNEXE 1. Primers used in this work
All the primers used in this work and their sequences are shown in the next table.
Primer Name Sequence (5'to 3') Description
158AlconFl gtgcgctgatggtggagatccg Amplification of the 
gene sco6998
158AlconRl agggcctgatcggccagctgctg
SpmCssF gtataggaacttcgaagttcccgccagcctcgcagagcaggattc Amplification of the 
spectinomycin cassette
SpmCssR ctagagaataggaacttcggaataggaacttcatgagctc
SpecIntF ttatccagctaagcgcgaactgc Internal primer for the 
spectinomycin cassette
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ANNEXE 2. Sequence of the plasmid pU778. (Obtained from (Gust et a l, 2002)
LOCUS p iJ 7 7 8  4 3 7 7  bp  DNA CIRCULAR SYN 0 2 -A U G -2 0 0 2
DEFINITION L i g a t i o n  o f  S p e c , S t r e p - o r i T  d i s r u p t i o n  c a s s e t t e  i n t o  t h e  EcoRV s i t e  o f  
p B l u e s c r i p t  SK (+)
ACCESSION p I J 7 78  
KEYWORDS .
SOURCE U nknow n.
ORGANISM Unknown  
U n c l a s s i f i e d .
REFERENCE 1 ( b a s e s  1 t o  4 3 7 7 )
AUTHORS G u s t ' e t  a l . ,  2 0 0 3
JOURNAL Proc .  N a t l .  Acad.  S c i .  USA 1 0 0 ( 4 ) ,  1 5 4 1 - 1 5 4  6 
FEATURES L o c a t i o n / Q u a l i f i e r s  
CDS 6 9 9 . . 7 1 7
/r e g i o n = " p r i m i n g  s i t e  19  bp"
/p r o d u c t= " T G T  AGG CTG GAG CTG CTT C"
CDS c o m p le m e n t  ( 7 1 8 . . 7 5 1 )
/r e g io n = " F R T "
/p r o d u c t = " n a t u r a l  FRT s i t e "
CDS c o m p le m e n t  ( 7 9 8 . . 1 5 9 0 )
/g e n e = " a a d A "
/p r o d u c t = " s p e c t i n o m y c i n , s t r e p t o m y c i n  a d e n y l t r a n s f e r a s e  g e n e "
CDS 1 9 3 1 . .2 0 4 0  
/r e g io n = " o r iT "
/ p r o d u c t = " o r i g i n  o f  t r a n s f e r  (RK 2)"
CDS 2 0 4 9 . .2 0 8 2  
/r e g io n = " F R T "
/ p r o d u c t = " n a t u r a l  FRT s i t e "
CDS c o m p le m e n t  ( 2 0 9 1 . . 2 1 1 0 )
/r e g i o n = " p r i m i n g  s i t e  20  bp"
/p r o d u c t= " A T T  CCG GGG ATC CGT CGA CC"
CDS c o m p le m e n t  ( 3 3 8 6 . . 4 2 4 6 )
/g e n e = " a m p "
/ p r o d u c t = " b - l a c t a m a s e "
BASE COUNT 1 0 6 5  a 1 1 2 0  c  1 1 0 8  g 10 8 4  t  
ORIGIN
1 GGAAATTGTA AACGTTAATA TTTTGTTAAA ATTCGCGTTA AATTTTTGTT AAATCAGCTC 
61 ATTTTTTAAC CAATAGGCCG AAATCGGCAA AATCCCTTAT AAATCAAAAG AATAGACCGA 
1 21  GATAGGGTTG AGTGTTGTTC CAGTTTGGAA CAAGAGTCCA CTATTAAAGA ACGTGGACTC
1 81 CAACGTCAAA GGGCGAAAAA CCGTCTATCA GGGCGATGGC CCACTACGTG AACCATCACC
2 4 1  CTAATCAAGT TTTTTGGGGT CGAGGTGCCG TAAAGCACTA AATCGGAACC CTAAAGGGAG
30 1  CCCCCGATTT AGAGCTTGAC GGGGAAAGCC GGCGAACGTG GCGAGAAAGG AAGGGAAGAA
3 6 1  AGCGAAAGGA GCGGGCGCTA GGGCGCTGGC AAGTGTAGCG GTCACGCTGC GCGTAACCAC
4 21 CACACCCGCC GCGCTTAATG CGCCGCTACA GGGCGCGTCG CGCCATTCGC CATTCAGGCT
4 81 GCGCAACTGT TGGGAAGGGC GATCGGTGCG GGCCTCTTCG CTATTACGCC AGCTGGCGAA
54 1  AGGGGGATGT GCTGCAAGGC GATTAAGTTG GGTAACGCCA GGGTTTTCCC AGTCACGACG
60 1  TTGTAAAACG ACGGCCAGTG AATTGTAATA CGACTCACTA TAGGGCGAAT TGGGTACCGG
66 1  GCCCCCCCTC GAGGTCGACG GTATCGATAA GCTTGATGTG TAGGCTGGAG CTGCTTCGAA
7 2 1  GTTCCTATAC TTTCTAGAGA ATAGGAACTT CGGAATAGGA ACTTCATGAG CTCAGCCAAT
7 8 1  CGACTGGCGA GCGGCATCTT ATTTGCCGAC TACCTTGGTG ATCTCGCCTT TCACGTAGTG
8 4 1  GACAAATTCT TCCAACTGAT CTGCGCGCGA GGCCAAGCGA TCTTCTTCTT GTCCAAGATA
901 AGCCTGTCTA GCTTCAAGTA TGACGGGCTG ATACTGGGCC GGCAGGCGCT CCATTGCCCA
961 GTCGGCAGCG ACATCCTTCG GCGCGATTTT GCCGGTTACT GCGCTGTACC AAATGCGGGA
1 0 2 1  CAACGTAAGC ACTACATTTC GCTCATCGCC AGCCCAGTCG GGCGGCGAGT TCCATAGCGT
1 0 8 1  TAAGGTTTCA TTTAGCGCCT CAAATAGATC CTGTTCAGGA ACCGGATCAA AGAGTTCCTC
1 1 4 1  CGCCGCTGGA CCTACCAAGG CAACGCTATG TTCTCTTGCT TTTGTCAGCA AGATAGCCAG
1 2 0 1  ATCAATGTCG ATCGTGGCTG GCTCGAAGAT ACCTGCAAGA ATGTCATTGC GCTGCCATTC
1 2 6 1  TCCAAATTGC AGTTCGCGCT TAGCTGGATA ACGCCACGGA ATGATGTCGT CGTGCACAAC
1 3 2 1  AATGGTGACT TCTACAGCGC GGAGAATCTC GCTCTCTCCA GGGGAAGCCG AAGTTTCCAA
1 3 8 1  AAGGTCGTTG ATCAAAGCTC GCCGCGTTGT TTCATCAAGC CTTACGGTCA CCGTAACCAG
14 41 CAAATCAATA TCACTGTGTG GCTTCAGGCC GCCATCCACT GCGGAGCCGT ACAAATGTAC
1 5 0 1  GGCCAGCAAC GTCGGTTCGA GATGGCGCTC GATGACGCCA ACTACCTCTG ATAGTTGAGT
1 5 6 1  CGATACTTCG GCGATCACCG CTTCCCTCAT GACATTGCAC TCCACCGCTG ATGACATCAG
1 6 2 1  TCGATCATAG CACGATCAAC GGCACTGTTG CAAATAGTCG GTGGTGATAA ACTTATCATC
1 6 8 1  CCCTTTTGCT GATGGAGCTG CACATGAACC CATTCAAAGG CCGGCATTTT CAGCGTGACA
1 7 4 1  TCATTCTGTG GGCCGTACGC TGGTACTGCA AATACGGCAT CAGTTACCGT GAGCTGCATT
1 8 0 1  TTCCGCTGCA TAACCCTGCT TCGGGGTCAT TATAGCGATT TTTTCGGTAT ATCCATCCTT
1 8 6 1  TTTCGCACGA TATACAGGAT TTTGCCAAAG GGTTCGTGTA GACTTTCCTT GGTGTATCCA
1 9 2 1  ACGGCGTCAG CCGGGCAGGA TAGGTGAAGT AGGCCCACCC GCGAGCGGGT GTTCCTTCTT
1 9 8 1  CACTGTCCCT TATTCGCACC TGGCGGTGCT CAACGGGAAT CCTGCTCTGC GAGGCTGGCG
2 0 4 1  GGAACTTCGA AGTTCCTATA CTTTCTAGAG AATAGGAACT TCGAACTGCA GGTCGACGGA
2 1 0 1  TCCCCGGAAT ATCGAATTCC TGCAGCCCGG GGGATCCACT AGTTCTAGAG CGGCCGCCAC
2 1 6 1  CGCGGTGGAG CTCCAGCTTT TGTTCCCTTT AGTGAGGGTT AATTCCGAGC TTGGCGTAAT
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2 2 8 1
2 3 4 1
2 4 0 1
2 4 6 1
2 5 2 1
2 5 8 1
2 6 4 1
2 7 0 1
2 7 6 1
2 8 2 1
2 8 8 1
2 9 4 1
3 0 0 1
3 0 6 1
3 1 2 1
3 1 8 1
3 2 4 1
3 3 0 1
3 3 6 1
3 4 2 1
3 4 8 1
3 5 4 1
3 6 0 1
3 6 6 1
3 7 2 1
3 7 8 1
3 8 4 1
3 9 0 1
3 9 6 1
4 0 2 1
4 0 8 1
4 1 4 1
4 2 0 1
4 2 6 1
4 3 2 1
/ /
CATGGTCATA GCTGTTTCCT 
GAGCCGGAAG CATAAAGTGT 
TTGCGTTGCG CTCACTGCCC 
GAATCGGCCA ACGCGCGGGG 
TCACTGACTC GCTGCGCTCG 
CGGTAATACG GTTATCCACA 
GCCAGCAAAA GGCCAGGAAC 
GCCCCCCTGA CGAGCATCAC 
GACTATAAAG ATACCAGGCG 
CCCTGCCGCT TACCGGATAC 
ATAGCTCACG CTGTAGGTAT 
TGCACGAACC CCCCGTTCAG 
CCAACCCGGT AAGACACGAC 
GAGCGAGGTA TGTAGGCGGT 
CTAGAAGGAC AGTATTTGGT 
TTGGTAGCTC TTGATCCGGC 
AGCAGCAGAT TACGCGCAGA 
GGTCTGACGC TCAGTGGAAC 
AAAGGATCTT CACCTAGATC 
TATATGAGTA AACTTGGTCT 
CGATCTGTCT ATTTCGTTCA 
TACGGGAGGG CTTACCATCT 
CGGCTCCAGA TTTATCAGCA 
CTGCAACTTT ATCCGCCTCC 
GTTCGCCAGT TAATAGTTTG 
GCTCGTCGTT TGGTATGGCT 
GATCCCCCAT GTTGTGCAAA 
GTAAGTTGGC CGCAGTGTTA 
TCATGCCATC CGTAAGATGC 
AATAGTGTAT GCGGCGACCG 
CACATAGCAG AACTTTAAAA 
CAAGGATCTT ACCGCTGTTG 
CTTCAGCATC TTTTACTTTC 
CCGCAAAAAA GGGAATAAGG 
AATATTATTG AAGCATTTAT 
TTTAGAAAAA TAAACAAATA
GTGTGAAATT GTTATCCGCT 
AAAGCCTGGG GTGCCTAATG 
GCTTTCCAGT CGGGAAACCT 
AGAGGCGGTT TGCGTATTGG 
GTCGTTCGGC TGCGGCGAGC 
GAATCAGGGG ATAACGCAGG 
CGTAAAAAGG CCGCGTTGCT 
AAAAATCGAC GCTCAAGTCA 
TTTCCCCCTG GAAGCTCCCT 
CTGTCCGCCT TTCTCCCTTC 
CTCAGTTCGG TGTAGGTCGT 
CCCGACCGCT GCGCCTTATC 
TTATCGCCAC TGGCAGCAGC 
GCTACAGAGT TCTTGAAGTG 
ATCTGCGCTC TGCTGAAGCC 
AAACAAACCA CCGCTGGTAG 
AAAAAAGGAT CTCAAGAAGA 
GAAAACTCAC GTTAAGGGAT 
CTTTTAAATT AAAAATGAAG 
GACAGTTACC AATGCTTAAT 
TCCATAGTTG CCTGACTCCC 
GGCCCCAGTG CTGCAATGAT 
ATAAACCAGC CAGCCGGAAG 
ATCCAGTCTA TTAATTGTTG 
CGCAACGTTG TTGCCATTGC 
TCATTCAGCT CCGGTTCCCA 
AAAGCGGTTA GCTCCTTCGG 
TCACTCATGG TTATGGCAGC 
TTTTCTGTGA CTGGTGAGTA 
AGTTGCTCTT GCCCGGCGTC 
GTGCTCATCA TTGGAAAACG 
AGATCCAGTT CGATGTAACC 
ACCAGCGTTT CTGGGTGAGC 
GCGACACGGA AATGTTGAAT 
CAGGGTTATT GTCTCATGAG 
GGGGTTCCGC GCACATTTCC
CACAATTCCA CACAACATAC 
AGTGAGCTAA CTCACATTAA 
GTCGTGCCAG CTGCATTAAT 
GCGCTCTTCC GCTTCCTCGC 
GGTATCAGCT CACTCAAAGG 
AAAGAACATG TGAGCAAAAG 
GGCGTTTTTC CATAGGCTCC 
GAGGTGGCGA AACCCGACAG 
CGTGCGCTCT CCTGTTCCGA 
GGGAAGCGTG GCGCTTTCTC 
TCGCTCCAAG CTGGGCTGTG 
CGGTAACTAT CGTCTTGAGT 
CACTGGTAAC AGGATTAGCA 
GTGGCCTAAC TACGGCTACA 
AGTTACCTTC GGAAAAAGAG 
CGGTGGTTTT TTTGTTTGCA 
TCCTTTGATC TTTTCTACGG 
TTTGGTCATG AGATTATCAA 
TTTTAAATCA ATCTAAAGTA 
CAGTGAGGCA CCTATCTCAG 
CGTCGTGTAG ATAACTACGA 
ACCGCGAGAC CCACGCTCAC 
GGCCGAGCGC AGAAGTGGTC 
CCGGGAAGCT AGAGTAAGTA 
TACAGGCATC GTGGTGTCAC 
ACGATCAAGG CGAGTTACAT 
TCCTCCGATC GTTGTCAGAA 
ACTGCATAAT TCTCTTACTG 
CTCAACCAAG TCATTCTGAG 
AATACGGGAT AATACCGCGC 
TTCTTCGGGG CGAAAACTCT 
CACTCGTGCA CCCAACTGAT 
AAAAACAGGA AGGCAAAATG 
ACTCATACTC TTCCTTTTTC 
CGGATACATA TTTGAATGTA 
CCGAAAAGTG CCACCTG
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